rfhg_162226.1

Basic information about the TSS

---

TSS ID: rfhg_162226.1 Species: human Chr: chr13		Start: 99501398 End: 99501410 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2684232,EH38E1692648)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC110656:7 GQ891421:7 GeneID: 9375 HGNC/MGI_ID: HGNC:11865 UniProt_ID: Nearer transcript ids and distances: AK315210:9 AK290514:9 ENST00000376387.5:62 NM_004800.3:62 U81006:64 AK225800:64 BC130293:130 view more...

Gene_name: TM9SF2 Gene_symbol: TM9SF2 Gene_synonyms: P76 Gene_source: HGNC:11865

TATA-Box annotation

---

Distance to TSS:	-68
Nearest PromoterID:	NM_004800
Entrez ID:	9375
Nearest Unigene:	Hs.607896
Nearest Refseq:	NM_004800
Nearest Ensembl:	ENSG00000125304
Gene Name:	TM9SF2
Gene Alias:	P76
Gene Type:	protein-coding
CpG%:	0.083333
GC%:	0.615385
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TM9SF2 p2@TM9SF2 p3@TM9SF2 p4@TM9SF2 p5@TM9SF2 p6@TM9SF2
Sample		p1@TM9SF2	p2@TM9SF2	p3@TM9SF2	p4@TM9SF2	p5@TM9SF2	p6@TM9SF2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	21.82	30.00	5.26	6.43	4.29	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	20.03	31.97	3.64	5.46	2.02	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.22	31.44	3.86	5.02	3.28	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	19.54	27.03	3.53	4.37	2.70	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	28.57	27.22	3.82	5.62	2.25	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	21.90	27.91	3.10	4.46	2.33	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	29.41	39.87	6.75	5.23	3.49	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	27.13	36.82	6.54	6.78	3.63	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	25.65	32.06	5.34	7.27	4.49	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	10.43	20.29	3.48	1.74	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.91	19.40	3.23	3.23	2.02	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.38	22.77	2.85	3.66	2.03	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.60	13.86	7.74	6.61	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.04	12.78	6.31	6.77	1.80	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	16.69	11.42	8.56	5.27	1.32	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	17.86	14.84	5.28	6.04	1.51	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	18.78	13.10	6.55	5.24	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.98	16.87	5.06	6.33	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	17.59	8.53	4.80	3.20	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.35	13.84	7.82	5.12	2.56	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	19.78	11.63	7.22	5.75	1.20	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	16.74	16.05	5.01	4.49	1.38	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	17.58	13.70	7.24	6.33	0.39	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	17.47	15.77	5.10	5.10	0.97	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	17.03	11.87	4.64	5.68	1.03	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.04	13.61	7.28	9.18	1.27	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	14.84	10.44	4.95	6.04	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	17.45	11.08	7.54	7.78	2.36	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	18.25	11.47	4.85	5.01	1.29	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	16.11	12.12	7.24	6.70	1.27	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.75	12.35	6.28	3.56	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	18.56	14.07	6.06	3.91	1.37	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	19.63	15.19	5.91	5.70	1.48	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	20.62	18.14	7.92	5.44	0.82	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	16.08	8.23	7.85	5.80	2.24	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	16.29	13.80	6.32	6.32	1.72	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	14.31	11.04	9.20	5.52	2.66	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	17.13	13.50	7.25	4.43	2.01	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	16.75	15.94	6.48	4.86	0.81	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.92	15.12	8.88	4.08	2.40	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.17	12.94	6.35	5.41	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	21.37	15.23	6.59	4.54	0.59	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	17.29	13.29	6.12	6.96	2.53	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.53	16.26	5.59	6.82	1.40	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	18.87	16.26	9.64	6.22	2.41	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	19.08	15.35	5.12	5.82	1.16	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.47	17.75	8.64	3.84	3.36	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	18.78	17.29	6.26	5.96	1.19	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.67	16.52	6.46	6.94	1.44	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.40	13.35	7.89	5.66	1.62	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	19.27	19.27	3.89	7.17	2.46	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.79	18.46	5.78	8.01	1.78	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	153.91	111.94	27.98	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.10	17.39	4.26	10.65	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	13.92	19.55	6.63	6.63	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	53.69	50.34	7.55	5.03	0.84	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	28.01	29.85	5.05	6.43	1.38	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	17.83	19.45	6.16	11.99	3.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.66	21.52	8.67	8.03	1.93	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	26.72	32.69	3.14	9.74	2.20	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	18.33	22.56	4.94	6.35	0.00	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	23.55	22.43	5.61	7.85	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	35.83	41.40	5.57	7.17	0.80	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	30.24	34.66	6.12	5.10	2.38	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	26.32	30.22	8.12	15.92	4.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.88	37.98	8.52	6.74	1.77	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	193.97	64.66	0.00	0.00	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	173.74	134.26	15.79	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	25.35	31.20	7.31	8.29	2.44	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	24.30	33.22	7.44	6.45	1.98	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	23.92	34.71	3.75	7.51	1.88	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	27.82	30.47	5.30	8.28	2.98	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	25.98	32.17	8.35	8.66	3.09	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	25.99	25.68	7.03	7.34	0.92	1.53
Adipocyte - breast, donor1	11376-118A8	59.71	53.22	21.07	15.20	3.80	1.90
Adipocyte - breast, donor2	11327-117E4	40.59	36.10	14.92	9.14	3.53	1.76
Adipocyte - omental, donor1	11473-119C6	60.94	59.54	21.63	16.92	5.09	2.67
Adipocyte - omental, donor2	11474-119C7	30.65	37.37	17.94	1.49	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	33.83	41.86	15.74	6.36	3.01	1.00
Adipocyte - perirenal, donor1	11476-119C9	44.02	45.94	14.67	7.02	2.55	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	17.59	5.50	6.60	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	42.00	42.90	18.06	11.29	2.26	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	22.76	21.03	10.25	6.26	1.22	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	53.98	36.96	14.08	10.37	1.76	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	36.81	37.83	9.52	3.60	1.80	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	45.72	41.54	13.10	7.25	1.67	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	32.92	21.16	5.88	4.70	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	40.30	42.63	14.56	8.61	1.37	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	28.40	30.34	12.59	8.07	2.90	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	23.99	23.99	7.46	6.40	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	22.26	23.93	8.35	4.45	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	24.95	27.45	9.57	9.15	1.25	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	27.13	35.67	11.05	6.53	2.26	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	28.47	24.87	10.80	7.85	1.96	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	14.61	18.57	6.39	5.78	1.83	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	29.61	34.25	7.96	3.09	2.21	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	6.45	6.81	3.59	0.36	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	3.59	1.20	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	38.32	49.47	15.11	5.58	3.06	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	31.80	5.02	1.67	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	24.45	28.35	8.22	6.57	1.23	0.21
Anulus Pulposus Cell, donor1	11248-116E6	48.63	35.13	15.45	11.90	2.63	0.69
Anulus Pulposus Cell, donor2	11463-119B5	38.21	25.47	11.76	6.86	3.18	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	34.15	22.46	9.44	5.84	3.15	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	36.03	33.86	10.85	9.55	5.21	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	19.26	8.56	2.14	6.42	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	36.17	37.07	13.15	5.98	1.49	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	35.41	30.35	5.06	5.06	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.10	20.46	4.62	5.94	1.98	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	30.86	23.39	8.77	7.47	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	25.24	28.16	9.22	4.85	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	29.10	18.41	4.75	6.53	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	33.14	27.87	10.92	7.16	2.64	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	24.67	27.58	6.53	2.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	26.33	15.05	3.76	6.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	38.55	35.91	12.68	8.07	1.81	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	30.03	30.03	12.28	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	31.52	29.86	6.94	7.24	1.81	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	32.68	35.90	9.11	9.11	2.14	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	34.58	26.26	11.15	6.05	2.08	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	29.13	26.73	6.95	8.55	2.94	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	46.82	23.41	8.78	8.78	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	36.49	29.52	8.79	6.30	1.82	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	18.01	4.80	7.20	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	24.78	7.08	14.16	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	34.82	29.50	11.49	7.20	2.57	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	32.04	30.58	8.74	4.85	3.88	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	39.46	31.49	7.97	7.59	2.28	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	35.13	25.44	4.85	6.06	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	31.92	32.49	14.25	5.70	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.71	25.23	10.26	4.49	2.14	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	21.68	19.36	7.48	5.42	1.55	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	22.52	28.62	8.91	8.45	2.35	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	31.83	23.47	12.22	7.72	2.25	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	15.70	8.56	4.28	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	35.10	22.81	13.45	9.36	2.34	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	31.01	28.30	9.03	7.23	3.01	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	14.26	9.50	2.38	4.75	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	32.55	36.62	9.15	5.59	4.58	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	36.42	23.69	8.40	6.88	1.78	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	29.86	11.44	5.72	7.62	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	25.89	30.64	11.22	5.18	2.16	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	30.91	26.88	9.10	6.35	2.12	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	25.81	19.43	5.22	3.77	2.32	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	29.29	33.07	12.28	7.56	3.78	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	29.50	28.65	7.63	6.10	1.19	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	20.85	2.32	11.58	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	33.80	33.80	6.34	16.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	27.02	29.59	10.29	7.50	1.72	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	37.90	16.85	4.81	4.81	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	29.16	23.33	7.29	3.64	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	29.88	27.82	6.67	5.06	2.76	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	35.70	22.95	10.20	7.65	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	37.88	32.54	9.41	6.86	1.27	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	45.21	27.25	10.53	7.64	1.86	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	33.05	19.58	5.81	2.14	1.22	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	36.81	34.89	9.56	8.60	3.82	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	37.25	26.61	9.98	5.10	2.44	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	16.78	4.58	4.58	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	30.46	30.46	8.86	9.42	2.22	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	34.42	24.89	8.74	7.41	1.06	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	24.35	23.26	7.63	4.36	2.18	0.36
Astrocyte - cerebellum, donor1	11500-119F6	26.16	28.62	7.61	5.53	1.97	0.25
Astrocyte - cerebellum, donor2	11580-120F5	16.09	14.55	4.79	4.11	1.54	0.17
Astrocyte - cerebellum, donor3	11661-122F5	6.92	11.12	3.78	2.52	0.84	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	29.63	25.80	13.59	9.76	1.74	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	27.34	23.62	9.71	8.09	2.91	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	28.94	25.06	13.87	11.63	2.39	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	44.73	20.07	9.17	3.44	1.26	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	43.85	21.42	6.39	5.01	1.88	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	40.63	19.12	8.76	3.98	1.37	0.46
Basophils, donor1	12241-129G9	51.52	20.92	7.06	4.18	0.52	1.05
Basophils, donor2	12242-129H1	75.41	28.50	8.66	7.22	1.44	1.08
Basophils, donor3	12243-129H2	53.21	22.93	12.49	7.20	2.65	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	13.15	14.45	6.90	2.80	0.86	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	7.77	6.86	3.20	1.37	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	21.52	14.35	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	14.44	16.32	5.65	1.26	0.63	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	21.21	14.76	8.11	4.37	1.25	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	16.81	19.34	9.67	4.15	2.53	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	20.15	25.91	14.58	7.20	2.70	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	48.64	21.23	6.49	5.05	1.24	1.55
Burkitt's lymphoma cell line:RAJI	10476-106I8	82.68	30.74	11.18	7.69	2.56	2.33
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	83.14	19.19	4.80	7.67	2.24	2.88
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	20.68	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	45.08	22.54	10.14	8.45	3.38	1.13
CD14+ Monocytes, donor2	11305-117B9	41.02	23.94	10.58	5.75	3.16	0.37
CD14+ Monocytes, donor3	11381-118B4	34.91	22.39	11.20	7.03	2.20	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	107.56	108.12	39.91	30.29	5.09	8.21
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	104.25	79.98	46.63	18.95	5.69	3.41
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	123.61	107.50	48.00	24.66	6.90	6.25
CD14+ monocytes - mock treated, donor1	11863-125A9	65.91	39.32	18.65	9.11	3.04	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	43.75	29.87	12.07	8.75	3.02	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	60.41	34.59	10.19	12.32	2.84	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	45.20	23.94	11.05	5.69	2.01	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	33.12	23.18	10.49	4.97	0.83	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	41.16	28.02	7.69	5.95	2.98	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	46.80	27.41	9.79	8.62	1.17	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	36.68	25.46	12.46	7.30	3.03	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	62.24	49.84	9.79	8.27	2.83	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	48.23	23.18	10.30	7.96	2.81	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	42.24	30.63	9.50	6.34	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	47.70	27.73	16.64	8.87	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	49.24	28.56	13.39	6.69	1.93	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	37.71	25.94	7.78	4.99	0.80	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	51.22	47.68	9.58	8.95	2.71	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	40.95	41.18	10.75	7.09	2.06	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	37.32	30.31	6.79	5.66	3.39	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	31.86	24.44	4.80	6.55	4.80	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	57.03	46.80	14.53	9.41	2.69	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	58.10	36.64	16.40	10.47	2.44	1.40
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	80.80	60.18	17.67	11.78	5.89	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	36.74	30.31	11.94	6.61	2.57	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	36.99	21.14	6.69	6.69	2.82	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	32.47	29.83	9.21	6.14	2.63	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	54.93	30.86	13.43	10.29	3.14	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	39.40	30.11	13.38	4.83	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	63.80	47.21	14.87	9.27	3.45	1.51
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	38.08	37.67	15.15	8.19	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	36.62	23.88	4.87	5.10	3.71	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	40.60	28.30	8.58	8.58	2.09	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	59.72	40.76	13.30	7.63	2.62	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	53.82	34.42	16.63	7.16	1.85	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	66.72	46.14	12.78	9.53	3.68	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	73.66	47.03	22.89	19.15	6.07	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	66.89	46.98	23.05	11.70	5.06	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	84.95	61.76	25.20	18.73	7.36	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	45.93	26.28	9.19	5.61	0.77	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	48.08	40.18	14.27	6.59	2.20	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	58.11	38.32	12.00	10.32	2.95	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	83.32	32.52	6.10	6.10	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	83.39	29.83	10.17	10.17	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	94.24	35.21	8.28	3.11	0.00	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	123.13	34.11	13.33	6.93	1.07	3.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	102.92	40.74	9.11	5.90	1.61	3.75
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	77.92	29.48	6.32	3.51	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	83.14	25.88	7.84	4.71	1.57	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	89.64	32.96	6.59	3.95	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	69.86	27.94	3.29	2.47	3.29	2.47
CD19+ B Cells, donor2	11624-122B4	71.09	22.49	4.35	2.90	0.73	1.45
CD19+ B Cells, donor3	11705-123B4	73.70	21.20	4.54	4.54	1.51	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	48.49	38.79	18.18	8.89	1.62	3.23
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	36.35	19.18	15.18	8.39	2.00	2.00
CD34+ Progenitors, donor1	11545-120B6	58.23	14.06	3.01	4.02	1.00	3.01
CD34+ Progenitors, donor2	11625-122B5	52.81	17.42	4.49	2.81	1.12	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	100.33	27.05	7.14	8.27	3.38	3.01
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	107.56	27.28	10.15	6.31	2.93	4.28
CD4+ T Cells, donor1	11225-116C1	52.13	19.28	16.78	10.00	2.14	1.43
CD4+ T Cells, donor2	11306-117C1	37.97	18.98	9.80	8.57	2.45	3.67
CD4+ T Cells, donor3	11382-118B5	40.56	16.16	9.45	6.71	3.05	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	76.57	46.71	11.23	9.44	2.81	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	78.38	45.82	12.35	7.64	2.92	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	76.75	48.29	9.77	8.05	3.45	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	39.82	15.65	4.27	9.01	2.84	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	40.03	18.26	5.62	5.62	2.11	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	16.48	9.89	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	82.23	44.66	12.57	9.68	1.88	2.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	55.75	34.40	11.86	10.17	3.05	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	67.06	33.53	9.67	10.16	2.74	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	52.90	28.69	10.31	5.83	1.34	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	64.99	26.90	7.34	6.64	1.75	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	76.56	43.12	8.80	10.56	1.32	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	51.86	39.21	18.13	8.85	4.22	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	39.89	28.46	11.22	8.52	2.08	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	41.43	24.73	9.36	10.36	2.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	39.16	17.95	9.52	9.25	2.18	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	44.48	18.76	17.69	9.11	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	41.24	30.48	7.17	7.17	7.17	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	78.62	50.99	14.28	18.91	3.71	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	71.48	45.06	16.46	14.30	3.68	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	79.86	53.38	17.23	17.23	4.41	1.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	43.99	19.72	6.57	5.06	1.52	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	48.09	23.40	13.86	4.33	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	46.63	35.30	7.84	9.59	4.79	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	78.19	28.21	13.86	6.43	3.96	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	76.62	36.00	12.92	10.16	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	76.77	22.33	5.58	9.77	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	92.22	41.54	18.00	12.74	2.77	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	87.85	45.15	15.95	13.74	3.19	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	75.46	27.72	10.78	13.86	4.62	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	88.46	34.02	17.91	8.59	2.51	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	94.18	34.62	22.16	13.85	5.54	1.38
CD8+ T Cells, donor1	11226-116C2	58.28	16.70	9.82	4.91	0.33	1.31
CD8+ T Cells, donor2	11307-117C2	62.32	13.52	7.88	4.51	0.75	0.38
CD8+ T Cells, donor3	11383-118B6	55.55	14.39	8.33	4.29	1.77	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.55	8.26	2.52	5.05	1.15	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8.87	10.30	3.35	2.16	1.44	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	8.75	7.11	1.37	3.56	0.82	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	10.81	12.61	2.40	4.20	0.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	10.80	8.88	2.64	4.32	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.91	7.73	2.05	4.32	1.36	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.91	9.78	1.74	3.69	1.52	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.05	9.21	1.05	3.95	1.84	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.73	5.16	2.58	4.92	0.70	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	10.57	11.17	1.51	4.53	1.21	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.36	9.59	1.45	3.78	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	11.99	9.06	4.26	2.66	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	8.32	3.50	1.75	1.75	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.11	6.38	0.91	0.46	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	3.73	4.48	1.49	1.49	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.16	8.64	3.24	3.96	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	9.49	9.78	2.88	3.16	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.25	7.54	2.83	2.36	0.94	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.73	8.24	2.22	3.49	0.63	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.69	8.00	1.23	2.77	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	8.66	9.94	2.56	6.09	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.56	10.33	1.53	2.29	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.09	7.88	3.15	2.36	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	4.54	2.27	3.78	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.82	4.82	4.01	4.01	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	5.60	1.40	2.10	3.50	2.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	6.01	8.01	2.00	2.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	34.73	34.73	7.31	7.31	3.66	1.83
Cardiac Myocyte, donor2	11605-120I3	40.02	23.22	7.41	6.92	3.46	0.00
Cardiac Myocyte, donor3	11686-122I3	39.36	29.57	14.63	12.42	2.32	1.05
Chondrocyte - de diff, donor1	11261-116G1	48.19	51.65	23.92	14.21	3.12	0.69
Chondrocyte - de diff, donor2	11338-117F6	33.41	36.25	9.95	6.04	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	38.23	29.81	10.81	6.49	2.05	0.34
Chondrocyte - re diff, donor2	11339-117F7	61.77	91.32	28.65	19.70	5.37	0.90
Chondrocyte - re diff, donor3	11411-118E7	42.46	37.61	19.82	18.20	4.45	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	39.02	29.72	13.66	9.41	1.95	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	33.35	22.02	11.76	7.27	2.14	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	38.32	24.69	11.68	9.65	2.65	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	50.16	45.30	28.79	30.26	6.97	0.37
Corneal Epithelial Cells, donor1	11526-119I5	9.88	8.78	3.07	2.20	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	12.51	17.06	5.69	3.41	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.50	8.18	4.86	3.07	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	71.65	57.78	23.11	15.35	4.29	2.31
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	91.47	54.57	18.92	15.46	3.78	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	127.68	65.56	31.06	6.90	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	61.45	46.54	15.77	13.71	4.64	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	263.75	95.32	33.48	12.30	2.39	8.54
Dendritic Cells - plasmacytoid, donor2	11309-117C4	342.10	96.62	15.02	10.45	1.96	18.28
Dendritic Cells - plasmacytoid, donor3	11385-118B8	329.08	107.44	28.07	10.16	0.48	9.68
Endothelial Cells - Aortic, donor0	11207-116A1	31.52	22.68	11.51	9.34	2.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	20.54	15.84	4.11	2.93	1.76	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	31.11	19.23	9.62	6.22	4.52	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	23.59	12.58	9.44	6.29	2.36	0.39
Endothelial Cells - Artery, donor1	11264-116G4	19.49	11.63	6.11	9.02	2.04	0.29
Endothelial Cells - Artery, donor2	11341-117F9	26.82	15.76	9.41	5.18	1.88	0.94
Endothelial Cells - Artery, donor3	11413-118E9	24.02	15.60	11.57	8.59	2.63	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.00	21.72	14.41	12.19	2.88	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	61.16	37.73	21.91	17.04	1.22	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	62.58	42.00	23.68	12.69	3.10	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	30.01	27.34	8.62	5.65	3.57	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	24.99	18.22	3.12	4.17	1.56	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	20.84	10.21	7.23	6.24	1.13	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	44.01	32.01	13.20	9.60	4.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	16.25	12.58	5.77	4.19	2.10	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	58.15	28.83	15.41	22.61	6.71	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	23.46	12.82	7.60	8.47	5.21	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	26.26	13.31	8.92	10.99	4.89	0.12
Endothelial Cells - Vein, donor1	11267-116G7	14.79	6.83	3.41	5.69	4.55	0.00
Endothelial Cells - Vein, donor2	11344-117G3	30.73	18.16	4.89	5.59	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	28.26	15.54	7.54	6.91	1.73	0.63
Eosinophils, donor1	12244-129H3	121.98	45.74	15.25	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	110.57	64.36	29.70	36.31	9.90	1.65
Eosinophils, donor3	12246-129H5	78.47	49.94	14.27	17.83	10.70	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	12.22	14.42	5.13	2.93	1.71	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	10.40	6.24	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	65.08	32.54	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	46.39	36.54	18.06	13.14	2.05	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.15	12.04	3.07	5.69	1.42	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.60	1.30	0.43	0.33	0.00	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	41.36	30.81	13.58	12.13	3.03	1.82
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	60.46	63.19	30.16	21.29	6.96	2.32
Fibroblast - Aortic Adventitial, donor2	11326-117E3	32.59	25.42	11.18	6.22	1.79	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	127.27	113.56	45.85	29.51	17.13	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.88	24.25	12.29	7.31	1.99	0.00
Fibroblast - Cardiac, donor1	11268-116G8	26.31	24.95	6.80	4.99	1.81	0.45
Fibroblast - Cardiac, donor2	11345-117G4	33.35	23.50	7.58	3.79	0.76	1.52
Fibroblast - Cardiac, donor3	11417-118F4	24.45	20.50	9.15	4.10	2.68	0.79
Fibroblast - Cardiac, donor4	11452-119A3	42.74	33.64	16.06	15.16	2.42	2.12
Fibroblast - Cardiac, donor5	11456-119A7	39.09	22.46	8.50	8.88	3.93	0.63
Fibroblast - Cardiac, donor6	11460-119B2	37.29	24.86	13.64	7.88	2.27	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	57.08	51.85	12.86	6.57	2.01	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	41.85	39.26	11.22	5.61	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	30.76	33.69	17.58	8.79	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	12.45	9.92	5.77	3.92	1.15	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	61.57	48.34	17.30	10.18	2.37	0.34
Fibroblast - Dermal, donor1	11269-116G9	24.65	26.06	9.63	7.98	4.46	0.23
Fibroblast - Dermal, donor2	11346-117G5	29.24	22.17	9.43	4.25	3.30	0.00
Fibroblast - Dermal, donor3	11418-118F5	27.44	20.91	9.31	9.07	2.18	0.24
Fibroblast - Dermal, donor4	11450-119A1	25.10	19.90	9.27	7.01	3.50	0.45
Fibroblast - Dermal, donor5	11454-119A5	25.30	26.34	10.64	9.77	4.54	0.17
Fibroblast - Dermal, donor6	11458-119A9	36.22	28.26	10.56	8.93	5.04	0.16
Fibroblast - Gingival, donor1	11237-116D4	38.31	37.90	13.95	12.29	1.67	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	33.54	26.99	9.43	7.34	4.19	1.31
Fibroblast - Gingival, donor2	11318-117D4	33.34	27.02	12.65	7.51	3.16	0.53
Fibroblast - Gingival, donor3	11394-118C8	27.46	27.27	13.73	7.64	2.03	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	32.21	40.52	10.39	5.19	1.04	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	30.84	28.19	9.16	9.16	0.70	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	42.87	32.27	9.67	9.35	2.96	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	33.40	28.13	9.20	6.22	1.89	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.88	10.23	3.18	2.47	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	33.78	30.27	10.53	7.31	1.90	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	38.72	30.68	13.09	11.32	3.27	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	36.20	30.28	9.98	10.75	4.28	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	43.14	32.14	11.89	8.22	1.03	1.61
Fibroblast - Lung, donor1	11270-116H1	16.31	6.80	2.72	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	43.27	28.35	14.92	10.45	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	21.95	18.36	10.13	5.91	1.69	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	33.32	36.65	11.66	3.33	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	30.77	5.59	2.80	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	7.84	5.88	1.40	1.68	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	40.19	42.22	18.67	8.12	3.25	0.41
Fibroblast - Mammary, donor2	11620-122A9	7.99	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	23.83	5.96	17.87	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	33.56	34.33	11.64	14.35	3.10	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	37.01	35.49	13.20	9.56	3.79	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	52.02	44.37	16.83	10.40	3.06	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	29.39	18.32	8.01	8.40	2.29	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	34.29	27.27	9.72	8.10	2.16	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	33.98	27.49	9.28	5.91	1.28	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	36.03	25.98	12.27	8.95	2.54	1.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	26.41	35.15	10.57	6.71	1.83	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	13.36	12.03	2.67	2.67	2.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.95	19.77	8.30	4.74	3.16	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	117.48	128.20	35.52	27.19	11.91	2.58
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.58	49.38	16.87	11.37	1.42	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	45.33	47.10	14.98	10.84	1.77	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	155.54	166.97	43.02	33.70	14.44	3.61
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	50.63	52.14	14.79	8.74	2.91	1.40
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	93.64	103.76	28.09	20.25	7.09	0.76
Fibroblast - skin normal, donor1	11553-120C5	49.39	52.01	21.00	10.83	3.61	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	241.21	185.07	68.37	56.34	21.45	2.41
Fibroblast - skin normal, donor2	11561-120D4	65.90	56.06	18.28	11.95	5.12	1.91
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	104.27	101.25	35.66	16.62	11.49	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	40.43	45.65	14.00	13.26	1.91	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	76.24	60.69	19.32	8.38	2.56	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	151.08	169.47	42.70	37.77	12.81	2.63
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	59.12	53.90	17.04	10.33	3.09	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	52.46	43.01	11.64	9.61	1.18	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	42.34	34.34	8.47	8.15	2.51	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	177.28	66.48	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	35.73	33.99	14.82	4.36	3.49	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	42.47	50.45	14.91	12.31	3.47	2.08
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	61.16	50.49	22.90	9.63	4.94	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	38.07	40.37	11.24	7.41	2.81	3.07
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	45.93	26.79	6.12	8.42	6.12	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	58.70	24.88	6.38	2.55	2.55	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	57.62	34.23	10.27	9.13	7.13	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	36.95	18.20	6.34	7.17	4.41	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	21.01	12.79	8.45	7.53	3.42	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	42.20	29.52	10.10	5.94	3.17	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	33.83	18.24	6.61	10.04	1.85	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	19.24	17.29	7.50	6.20	3.91	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	53.07	30.96	3.98	4.42	3.98	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	40.28	22.47	10.88	9.04	3.96	1.55
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	43.72	27.58	12.44	8.74	3.82	2.09
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	47.82	23.10	9.40	4.57	2.95	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	39.52	28.12	11.27	8.67	2.97	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	42.77	26.30	13.43	9.55	2.35	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	41.47	23.58	9.15	5.90	4.27	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	43.35	29.21	8.90	8.21	1.60	2.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	37.74	25.54	11.83	9.34	4.36	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	45.46	26.01	13.11	10.05	4.59	1.53
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	42.55	31.62	10.64	7.39	2.66	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	42.60	29.25	12.24	10.97	3.97	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	43.79	27.70	9.83	8.94	2.23	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	39.52	27.42	9.07	6.25	0.81	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	44.79	32.57	13.57	10.35	4.24	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	66.06	54.00	16.94	9.31	3.81	2.93
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	53.90	44.22	16.54	7.91	2.50	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	46.45	44.91	14.69	7.17	2.90	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	37.07	28.11	15.16	9.29	3.87	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	62.40	47.17	16.81	10.98	3.00	2.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	60.44	57.99	17.36	10.82	5.10	2.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.29	32.60	13.20	10.73	2.48	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	42.20	31.36	15.80	11.53	3.11	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	44.36	35.85	12.84	9.17	2.17	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	35.93	27.77	9.92	7.94	1.76	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	47.72	34.07	15.99	13.41	2.21	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	42.14	35.34	10.05	7.94	3.08	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	42.66	43.62	17.64	8.34	4.17	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.81	30.13	13.46	11.65	3.70	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	40.33	33.06	11.55	8.38	2.21	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	45.31	42.88	11.86	10.64	2.43	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	42.76	34.18	15.58	10.56	2.30	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	46.77	35.57	16.03	8.56	3.73	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	46.29	37.87	13.75	9.26	3.09	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	37.31	27.59	9.35	10.18	2.78	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	49.47	45.19	12.03	7.75	1.87	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	48.96	39.32	11.48	7.65	2.45	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.38	38.47	11.79	10.10	2.20	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	53.13	47.98	14.10	8.95	4.61	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	60.28	51.62	16.22	9.77	3.13	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	50.44	41.45	16.45	6.58	1.97	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	45.62	35.70	10.91	11.90	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	51.05	41.02	12.40	8.97	1.58	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	48.62	48.42	12.11	9.48	1.61	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	82.09	71.42	29.48	12.45	2.03	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	75.44	39.81	8.56	4.18	2.79	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	35.59	26.35	8.94	4.93	2.31	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	52.17	32.12	6.75	6.96	3.89	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	54.14	35.67	7.51	3.76	0.63	2.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	47.47	24.30	5.93	4.24	1.41	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	54.42	23.06	5.07	1.84	1.38	3.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	19.80	2.47	4.95	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	54.54	22.82	6.58	3.09	2.71	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	62.57	40.11	11.23	4.81	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	36.52	6.96	3.48	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	45.57	30.27	8.14	6.51	3.25	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	58.48	26.36	9.88	4.53	2.47	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	26.66	13.33	6.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	46.42	37.47	7.83	8.39	3.92	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	50.01	36.93	6.21	9.81	2.29	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	40.26	35.23	9.23	5.03	3.36	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	49.30	31.17	11.13	7.32	1.27	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	44.84	31.25	7.47	4.42	2.38	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	25.06	8.35	4.18	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	41.23	32.07	12.03	6.87	2.29	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	34.04	26.64	5.62	4.74	2.66	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	47.44	15.25	8.47	10.16	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	53.02	48.46	7.46	9.53	4.14	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	59.37	35.44	6.67	6.44	1.61	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	36.88	5.27	10.54	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	43.44	34.98	9.99	6.54	0.77	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	46.29	34.23	5.54	4.24	1.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	31.44	22.07	10.70	4.68	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	40.84	38.14	7.32	6.16	2.70	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	59.91	46.22	16.09	8.90	1.03	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	19.88	7.45	14.91	2.48	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	36.33	28.31	12.27	6.61	3.77	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	36.81	38.02	10.86	7.85	4.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.66	33.06	7.63	5.60	4.58	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	52.25	19.94	9.57	7.98	3.99	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	43.42	31.57	11.35	6.91	1.97	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	51.94	30.69	7.08	4.72	10.62	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	40.26	21.59	10.50	8.17	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	46.96	34.23	9.66	8.34	3.07	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.15	24.58	9.32	4.24	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	32.23	28.65	8.95	4.78	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	47.55	32.03	7.76	9.70	2.91	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	36.52	31.96	5.71	6.85	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	26.61	24.95	8.73	6.24	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	33.73	16.87	10.12	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	25.69	26.32	8.88	7.61	2.22	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.90	17.13	5.43	8.77	2.51	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	29.24	35.39	14.39	8.70	3.60	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	33.42	49.29	15.19	10.47	4.73	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	34.35	37.08	13.20	9.78	3.19	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	32.25	34.43	12.46	8.74	3.61	1.31
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	35.46	40.62	15.90	11.61	4.94	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	32.72	36.38	10.98	6.46	4.52	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	29.14	28.15	12.20	8.97	3.49	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	30.02	27.96	11.15	9.26	3.60	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	18.58	31.40	9.29	3.84	3.20	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	29.10	16.23	10.63	4.48	4.48	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	10.82	13.42	3.90	1.30	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	26.44	5.29	18.51	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	22.22	26.81	8.11	4.59	1.41	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.90	9.44	5.09	5.09	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	41.09	30.95	10.49	7.17	3.15	0.70
Hepatocyte, donor1	11523-119I2	72.64	106.53	25.42	27.84	12.11	4.84
Hepatocyte, donor2	11603-120I1	84.03	102.35	29.09	15.08	0.00	3.23
Hepatocyte, donor3	11684-122I1	53.99	73.01	28.84	21.47	7.36	4.91
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	40.47	26.11	6.53	2.61	2.61	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	81.27	83.55	42.12	25.69	6.64	3.67
Iris Pigment Epithelial Cells, donor1	11530-119I9	47.34	41.85	15.09	9.88	1.65	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	3.18	6.37	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	4.15	1.38	0.00	2.77	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	7.51	0.00	2.50	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	9.14	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	12.99	4.87	3.25	3.25	0.00	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	8.34	1.67	1.67	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	10.89	3.63	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	6.62	3.97	2.65	3.97	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	15.52	8.87	2.22	1.11	3.33	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	3.78	3.78	1.89	1.89	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	3.09	6.19	1.55	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	14.63	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	4.52	2.58	1.94	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	11.27	0.00	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	12.22	5.70	4.89	3.26	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	15.95	4.62	3.78	2.10	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.86	5.63	0.00	5.63	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	15.70	2.77	0.92	0.92	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	11.80	5.19	2.83	2.36	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	15.42	5.44	2.72	3.63	4.53	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	10.76	5.38	2.15	4.30	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	6.35	3.81	1.27	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	65.72	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.20	3.19	0.64	2.55	0.00	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	23.69	1.82	3.65	5.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	15.80	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.85	2.14	2.14	0.71	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	9.95	3.32	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	14.82	8.03	1.85	2.16	2.16	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	5.27	0.00	5.27	1.76	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	6.29	0.00	3.14	3.14	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	12.52	3.48	1.39	2.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	4.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	16.21	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	12.21	6.10	2.62	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	0.00	4.50	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	3.48	0.00	0.00	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	13.87	4.27	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	6.93	2.77	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	2.76	3.68	0.92	1.84	2.76	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	0.00	6.05	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	5.29	0.00	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	37.21	29.54	9.87	7.26	3.43	1.63
Keratinocyte - epidermal, donor2	11349-117G8	15.81	14.64	2.34	3.51	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	33.89	24.33	11.36	6.63	2.56	0.38
Keratinocyte - oral, donor1	11251-116E9	33.37	34.51	17.25	12.26	4.09	0.68
Keratocytes, donor1	11527-119I6	15.47	15.82	4.47	4.47	1.72	0.00
Keratocytes, donor2	11607-120I5	8.20	10.55	5.86	2.34	1.17	0.00
Keratocytes, donor3	11688-122I5	16.80	17.19	9.09	6.13	2.57	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	6.59	2.20	0.00	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	21.57	15.10	5.39	6.47	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	38.64	42.67	19.84	14.30	2.88	0.23
Lens Epithelial Cells, donor3	11690-122I7	71.85	54.79	22.30	17.26	3.63	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	35.69	19.09	10.79	8.77	2.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	22.61	11.44	6.70	9.49	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	40.77	19.36	8.97	11.96	1.42	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	18.82	15.06	6.99	5.91	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	23.32	6.93	6.62	4.73	1.89	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.24	12.08	7.22	6.36	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	28.73	20.11	9.44	4.92	4.10	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.41	5.81	2.78	3.29	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	24.91	10.42	6.90	4.64	1.83	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	26.11	16.22	7.52	6.72	1.19	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	29.28	11.25	7.56	7.56	0.58	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	11.48	8.33	4.81	4.07	1.30	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	24.04	9.41	9.41	6.62	2.44	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	22.18	8.35	5.01	5.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	20.46	14.97	7.14	6.59	1.65	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	24.02	14.17	9.24	4.00	0.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.47	7.79	6.86	2.81	1.87	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.04	12.08	8.05	6.40	2.56	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.34	16.46	5.59	9.22	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	15.23	7.03	3.81	4.10	1.46	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.69	6.47	4.48	4.23	1.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	23.76	16.00	11.15	6.30	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.93	11.04	7.81	7.27	1.35	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	29.37	14.53	7.72	8.17	2.12	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	18.14	11.41	5.18	6.74	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	26.17	15.08	6.91	6.07	0.84	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	22.26	11.43	7.67	6.47	1.65	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.20	13.76	11.01	4.82	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	23.14	10.54	5.27	6.02	1.13	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	17.39	10.50	5.51	5.51	1.48	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	28.11	15.99	6.30	3.39	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	6.28	5.95	3.31	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	19.82	10.65	5.82	4.83	0.99	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.99	18.88	10.37	5.18	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	29.65	13.59	5.19	5.19	0.74	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	21.31	11.00	5.91	5.22	1.10	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.95	15.12	6.11	4.50	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	32.56	14.00	8.22	7.30	2.13	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	32.61	15.40	10.36	8.26	2.10	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	26.31	13.87	5.69	4.27	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.60	7.27	2.91	2.91	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	15.09	7.31	4.67	4.36	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.28	12.18	7.16	6.80	1.07	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	18.95	11.76	4.90	6.53	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	15.07	7.53	4.47	3.77	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	35.15	21.04	10.64	7.67	2.48	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.27	5.38	3.84	4.10	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.90	11.93	3.88	5.97	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	31.72	9.06	4.53	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	28.38	6.90	9.97	5.37	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.13	20.78	2.97	5.20	3.71	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	12.27	13.12	5.50	2.96	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	15.47	18.99	2.81	4.92	2.81	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	10.27	12.14	1.87	2.80	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	16.49	6.18	4.64	2.58	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	14.27	2.38	3.57	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.06	15.83	5.20	6.11	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	16.58	19.49	6.40	4.65	3.78	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	23.86	25.21	8.55	8.10	3.60	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	19.10	20.46	7.32	6.37	2.71	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14.38	17.46	7.19	4.62	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	19.76	22.58	7.41	6.00	4.23	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.33	21.99	7.33	9.33	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.77	19.36	3.06	7.13	3.57	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	19.74	25.08	10.41	8.27	3.47	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.78	20.78	6.24	7.75	3.40	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	11.04	13.50	4.29	3.07	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	22.02	17.94	4.89	8.15	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	21.03	23.95	9.58	7.50	3.96	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.06	19.62	7.85	5.32	4.20	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	18.55	16.49	17.52	6.18	5.15	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.97	28.74	8.71	8.71	2.32	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	13.15	18.23	7.77	7.47	2.99	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	22.13	22.13	7.75	4.98	4.98	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	14.49	18.73	7.78	5.66	3.89	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	17.33	13.64	4.06	5.16	1.84	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	19.57	9.21	6.91	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	12.66	19.19	6.14	6.52	1.92	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.76	13.02	6.79	5.66	3.40	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	10.67	16.41	3.28	4.92	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	12.65	15.82	6.78	4.97	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	13.64	20.11	4.31	5.03	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	22.41	14.94	8.22	5.98	5.23	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	19.32	18.58	8.18	5.95	1.86	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	17.23	14.65	6.46	3.02	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	19.69	15.41	2.57	5.14	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.66	19.66	6.00	7.33	3.66	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	19.91	22.93	5.43	4.83	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	13.51	17.06	5.69	6.40	2.84	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	13.40	15.81	4.47	3.09	2.41	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.03	15.03	3.76	6.44	2.68	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	12.12	17.51	7.41	4.71	4.04	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.71	20.74	8.15	7.41	3.70	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	17.44	26.75	1.16	3.49	2.33	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	9.52	4.23	6.35	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.81	20.41	4.80	6.00	2.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	11.63	13.81	9.45	5.09	2.18	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	15.33	15.33	0.77	3.83	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	15.78	12.83	8.39	5.92	3.95	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	11.29	11.29	3.76	3.76	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.58	13.58	4.53	6.54	2.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	14.42	13.97	4.06	7.21	2.70	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	17.21	5.16	6.88	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.48	12.47	8.02	5.34	2.67	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.95	21.12	3.91	7.04	3.13	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	10.56	12.53	5.94	3.96	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	14.53	16.61	8.82	5.19	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	14.88	20.13	7.88	7.88	2.19	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.98	24.60	8.39	4.47	3.91	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	21.20	20.76	6.18	4.86	2.65	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.90	21.60	6.56	5.01	2.31	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.66	19.24	9.11	6.08	1.52	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	20.19	24.99	6.25	4.81	3.36	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	17.89	18.29	5.96	7.16	2.78	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.62	23.09	4.86	2.43	1.82	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.06	7.61	4.15	3.46	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	17.48	18.24	6.46	6.08	3.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.36	17.04	5.16	5.68	3.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	11.49	23.58	6.65	3.63	3.02	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.53	18.38	7.61	3.80	1.58	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.06	9.60	8.53	4.80	1.60	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.07	13.79	6.32	5.17	0.57	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.86	20.06	3.09	5.66	3.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.15	14.15	4.24	4.95	2.83	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	12.48	18.16	6.81	5.67	2.27	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	13.73	12.06	8.32	7.07	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.96	12.53	7.83	8.61	1.57	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	15.03	16.28	4.59	2.92	3.76	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	13.01	15.33	6.50	6.04	3.72	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.03	14.72	0.67	5.35	3.35	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.11	26.20	9.62	4.81	2.67	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.12	15.76	5.25	6.87	1.62	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14.68	10.10	4.59	1.84	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.89	18.67	3.56	3.56	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	19.38	18.24	5.13	5.13	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	8.44	9.97	3.83	1.53	3.07	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	19.70	18.06	5.47	6.57	1.64	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	17.37	18.71	4.01	3.56	2.23	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	12.48	16.90	8.58	4.94	2.60	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.89	19.23	7.96	3.32	5.97	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	10.39	8.31	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	82.73	68.37	34.42	16.87	4.10	1.82
Macrophage - monocyte derived, donor2	11313-117C8	54.50	47.53	23.31	10.09	4.04	1.47
Macrophage - monocyte derived, donor3	11389-118C3	56.89	45.75	17.96	13.63	4.85	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	39.83	31.33	12.74	6.90	1.59	1.59
Mallassez-derived cells, donor2	11929-125I3	61.95	94.60	20.76	8.56	2.85	1.90
Mallassez-derived cells, donor3	11930-125I4	51.01	69.77	16.96	7.51	3.47	0.97
Mammary Epithelial Cell, donor1	11273-116H4	34.78	27.20	12.65	11.06	4.19	0.50
Mammary Epithelial Cell, donor2	11350-117G9	29.24	31.27	11.00	5.79	4.34	0.29
Mammary Epithelial Cell, donor3	11422-118F9	23.20	17.71	5.74	5.74	1.00	0.25
Mast cell - stimulated, donor1	11487-119E2	78.64	52.88	8.81	7.46	0.68	6.78
Mast cell, donor1	11563-120D6	93.00	45.42	13.19	10.17	2.16	1.95
Mast cell, donor2	11565-120D8	85.29	26.75	13.37	15.75	5.65	2.38
Mast cell, donor3	11566-120D9	91.18	29.94	16.43	16.43	5.18	2.70
Mast cell, donor4	11567-120E1	81.55	31.20	14.71	14.71	3.19	3.01
Mast cell, expanded and stimulated, donor5	11940-126A5	108.12	65.32	17.19	15.75	4.55	1.77
Mast cell, expanded and stimulated, donor8	11942-126A7	90.47	36.19	7.59	10.51	1.75	7.59
Mast cell, expanded, donor5	11939-126A4	86.73	46.92	11.01	10.67	2.98	1.95
Mast cell, expanded, donor8	11941-126A6	84.52	39.83	9.37	7.36	1.84	2.51
Melanocyte - dark, donor1	11502-119F8	61.89	32.24	12.04	10.75	2.98	0.70
Melanocyte - dark, donor2	11582-120F7	42.22	21.80	7.27	7.61	2.42	1.04
Melanocyte - dark, donor3	11663-122F7	75.41	57.52	27.02	18.04	5.58	0.36
Melanocyte - light, donor1	11274-116H5	26.33	27.27	7.76	6.58	2.35	0.71
Melanocyte - light, donor2	11351-117H1	23.20	25.93	12.28	2.05	0.68	1.36
Melanocyte - light, donor3	11423-118G1	19.08	8.67	6.94	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	34.57	37.17	15.31	11.97	2.39	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	49.75	42.76	12.37	8.07	1.88	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	47.68	51.16	13.66	5.36	2.14	0.00
Meningeal Cells, donor1	11493-119E8	41.68	39.33	11.66	5.83	2.73	0.74
Meningeal Cells, donor2	11573-120E7	44.45	42.69	8.80	7.48	2.64	0.44
Meningeal Cells, donor3	11654-122E7	50.37	33.66	10.76	9.45	1.79	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	38.78	29.94	8.27	9.12	2.28	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	43.98	40.45	14.69	10.06	3.02	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	2.63	2.63	2.63	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	6.54	5.23	7.85	3.92	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	28.70	17.94	7.18	11.48	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	42.14	45.53	13.76	9.11	1.69	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	29.15	36.69	10.56	6.53	2.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	21.10	17.80	4.83	3.74	1.32	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.23	12.42	4.38	3.65	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.05	9.21	4.71	3.68	1.23	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	41.97	38.23	14.68	6.79	3.32	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.52	15.98	7.06	1.86	2.23	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	40.79	40.26	17.63	9.74	2.63	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	21.07	14.54	3.86	1.78	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	9.34	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	25.62	11.53	3.20	3.20	2.56	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	37.93	33.32	12.76	9.57	2.84	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	31.59	30.96	13.13	10.32	1.25	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	26.85	13.79	10.89	4.35	2.90	0.73
Mesothelial Cells, donor1	11247-116E5	34.74	39.51	14.32	8.75	1.59	1.06
Mesothelial Cells, donor2	12156-128G5	23.52	31.03	12.01	7.01	2.00	2.00
Mesothelial Cells, donor3	11402-118D7	22.84	22.04	9.97	6.72	1.01	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	29.71	17.55	9.45	5.40	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	80.04	58.86	17.24	10.84	6.40	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	52.12	44.17	18.85	13.55	7.66	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	17.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	67.26	44.63	17.67	11.47	2.79	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	48.75	32.57	15.35	11.20	4.15	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	9.26	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	70.57	52.55	18.77	10.76	5.01	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	42.82	28.86	10.24	9.31	3.72	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	56.90	43.89	14.83	10.16	3.86	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	44.35	43.95	15.44	11.48	4.36	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	46.90	27.43	10.62	9.73	3.54	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	45.21	34.19	14.44	14.44	4.94	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	5.26	2.63	2.63	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	44.78	30.56	8.70	6.58	0.85	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	9.21	1.84	4.60	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	40.54	34.28	8.94	7.45	2.68	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	6.71	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	42.65	28.60	10.04	5.77	3.76	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	39.22	34.22	12.83	9.74	3.80	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.61	5.53	2.76	2.21	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	41.67	34.54	9.21	7.37	3.45	1.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	38.70	35.76	15.78	9.25	5.68	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	42.60	31.59	11.01	8.97	3.67	1.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	47.84	43.12	12.23	6.22	2.79	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	37.34	29.34	13.78	7.34	4.22	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	37.45	39.86	9.20	6.57	3.72	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	14.70	13.18	6.08	2.53	2.53	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	11.60	4.97	1.66	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	39.68	31.26	6.52	5.16	1.90	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	42.35	32.94	9.12	6.47	4.41	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	25.08	7.63	6.54	2.18	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	39.89	40.85	5.29	8.65	4.81	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	54.43	40.82	11.21	12.01	6.40	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	6.86	1.37	6.86	4.11	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	41.05	41.55	5.01	7.51	5.01	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	107.79	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	2.04	0.00	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	49.49	44.67	10.95	7.88	3.07	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	22.07	5.52	4.41	3.31	4.41	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	9.61	8.33	3.84	1.92	2.56	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	47.35	51.07	12.15	8.93	1.49	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	21.57	14.61	3.48	5.57	1.39	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	2.21	2.21	6.63	4.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	55.73	57.44	12.65	5.47	3.42	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.94	25.38	3.50	5.69	2.19	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.65	10.65	2.84	1.78	2.13	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	50.50	60.32	10.10	8.14	1.96	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	54.45	30.34	4.57	5.40	2.91	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.99	5.83	1.75	0.58	1.17	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	52.19	51.28	10.26	4.52	2.71	2.11
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	78.47	61.36	15.44	5.43	3.76	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	21.66	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	46.18	35.10	6.46	4.62	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	62.03	52.36	9.68	6.83	6.83	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	29.85	28.05	8.29	5.53	2.49	1.11
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	59.34	50.27	9.07	5.96	3.37	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	45.47	40.32	11.58	4.29	5.15	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	11.43	11.43	1.27	1.91	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	42.70	37.36	7.21	5.60	1.60	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	63.76	51.19	12.87	7.18	4.19	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	23.87	20.91	7.20	4.38	1.55	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	56.38	53.51	6.05	2.87	3.82	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	74.08	65.90	13.49	3.10	6.19	2.87
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	23.13	18.96	3.79	4.55	3.41	2.28
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	55.12	55.40	9.38	5.97	3.41	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	71.04	68.58	16.22	8.85	5.16	1.97
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.82	14.99	3.26	2.61	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	45.87	54.69	10.29	4.70	2.35	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	63.43	59.68	14.13	7.78	2.59	2.59
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	54.82	45.34	16.07	5.36	2.06	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	43.18	43.77	9.23	6.25	1.19	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	41.44	45.20	26.37	7.53	11.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	55.25	58.81	12.48	10.69	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	88.06	72.94	19.06	9.86	4.27	1.97
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	49.44	44.18	9.47	3.16	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	64.45	60.29	16.61	12.85	3.16	1.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	55.88	54.02	18.63	11.18	4.66	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	67.97	64.97	22.16	17.65	3.76	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	49.81	42.35	15.98	8.79	3.20	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	55.19	64.58	11.08	10.63	2.15	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	51.57	35.36	9.58	8.84	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	65.59	71.09	16.12	9.16	1.47	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	51.33	28.00	12.44	12.44	6.22	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	38.48	32.60	6.95	6.41	1.60	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	23.18	11.59	15.46	7.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	63.63	54.54	7.07	5.05	4.04	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	38.37	27.83	10.12	6.32	1.26	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	29.96	36.77	9.53	6.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	14.62	8.90	5.09	2.54	1.27	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	27.53	32.39	9.72	6.48	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	15.10	6.04	4.53	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	51.39	11.42	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	29.36	3.26	6.52	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	61.78	80.79	9.50	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	25.10	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	47.18	44.16	16.16	10.13	4.52	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	36.58	32.40	13.59	8.88	2.61	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	26.03	24.03	4.67	6.67	2.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.93	8.76	3.34	5.01	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	33.08	33.66	7.42	12.55	2.85	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	30.32	25.53	7.98	9.58	4.79	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	13.60	8.16	4.08	6.12	4.76	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	82.69	49.62	9.19	14.70	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	21.35	20.09	5.86	9.63	2.09	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.08	19.06	8.37	10.23	2.09	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	22.97	21.35	7.57	10.00	5.94	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	33.64	30.90	6.94	10.09	2.94	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	267.23	77.94	22.27	33.40	22.27	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	22.34	26.80	4.96	8.44	1.49	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.98	24.36	5.14	8.39	2.44	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	22.89	23.57	8.61	8.84	6.35	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.90	21.88	7.35	7.68	2.61	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.25	27.89	7.29	7.11	0.73	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	25.46	24.40	6.37	6.37	2.12	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	21.01	4.80	6.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	41.02	35.11	6.89	10.17	1.64	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.42	17.89	8.13	7.32	3.25	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	21.52	26.63	9.52	7.58	1.41	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	24.61	24.61	4.22	7.03	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.55	24.36	8.27	8.73	2.30	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	26.03	30.53	8.68	13.18	3.21	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	37.59	29.66	4.83	8.97	1.38	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	98.61	68.27	15.17	5.06	5.06	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.72	24.73	9.13	7.13	0.89	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.05	23.71	3.81	9.74	2.12	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.84	15.19	4.27	8.07	0.47	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.47	32.62	7.73	12.02	2.15	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	135.42	9.03	18.06	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	15.66	20.33	4.67	9.33	5.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	15.78	16.68	7.66	8.12	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	21.03	17.86	7.94	9.52	1.98	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	25.07	26.00	8.36	13.93	2.79	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	24.97	26.49	9.84	11.35	1.89	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.20	21.51	6.52	8.15	4.56	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.84	11.33	3.49	4.36	2.61	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.00	26.23	9.95	8.14	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.99	27.34	5.29	7.94	3.53	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.25	28.59	9.97	9.31	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.83	24.31	8.93	7.94	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.25	17.23	6.13	8.80	2.30	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	45.06	48.39	18.45	17.24	4.54	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.64	30.72	10.61	8.40	3.09	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	15.59	29.14	6.78	13.55	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	61.31	10.22	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	30.48	29.87	14.63	9.75	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.90	20.14	10.39	8.81	0.94	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.41	17.55	9.68	14.22	6.96	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	25.32	27.69	6.33	12.66	3.16	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	44.21	43.08	6.80	19.27	4.53	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	101.16	55.64	5.06	10.12	0.00	5.06
Myoblast, donor1	11241-116D8	37.39	34.04	14.04	10.44	3.23	1.37
Myoblast, donor2	11322-117D8	46.41	39.12	13.23	10.93	3.07	0.19
Myoblast, donor3	11398-118D3	55.33	48.09	14.97	12.28	3.20	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	61.15	44.36	12.26	7.73	2.77	0.88
Natural Killer Cells, donor1	11230-116C6	64.27	16.61	6.77	4.92	1.85	1.54
Natural Killer Cells, donor2	11311-117C6	57.90	14.78	6.63	4.82	0.90	0.30
Natural Killer Cells, donor3	11387-118C1	58.71	16.20	6.81	5.34	1.10	0.55
Neural stem cells, donor1	11275-116H6	64.60	47.91	17.06	10.89	7.26	0.73
Neural stem cells, donor2	11352-117H2	67.40	55.84	19.26	5.78	5.78	0.00
Neurons, donor1	11494-119E9	63.72	47.79	10.24	17.07	9.10	1.14
Neurons, donor2	11574-120E8	44.69	46.67	13.87	13.43	2.86	0.22
Neurons, donor3	11655-122E8	55.09	38.64	17.27	13.98	4.93	1.64
Neutrophils, donor1	11233-116C9	111.36	103.01	51.97	52.90	3.71	0.93
Neutrophils, donor2	11314-117C9	78.27	55.08	31.89	40.58	8.70	5.80
Neutrophils, donor3	11390-118C4	147.82	94.68	76.36	62.31	9.77	4.89
Nucleus Pulposus Cell, donor1	11252-116F1	51.53	43.69	16.86	10.45	2.73	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	35.49	17.58	8.14	5.54	1.95	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	30.28	28.68	9.83	5.62	3.01	0.00
Olfactory epithelial cells, donor1	11933-125I7	31.52	28.22	10.60	7.43	2.06	0.41
Olfactory epithelial cells, donor2	11934-125I8	36.77	27.65	11.87	10.71	2.46	0.43
Olfactory epithelial cells, donor3	11935-125I9	30.31	26.33	11.01	9.99	1.82	0.57
Olfactory epithelial cells, donor4	11936-126A1	41.20	36.33	15.88	11.20	2.05	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	60.78	60.78	21.67	9.03	2.41	0.60
Osteoblast - differentiated, donor1	11276-116H7	37.22	37.01	17.65	10.85	4.25	1.06
Osteoblast - differentiated, donor2	11353-117H3	16.00	12.57	8.00	8.00	2.29	3.43
Osteoblast - differentiated, donor3	11425-118G3	22.97	10.55	8.07	4.34	0.62	0.62
Osteoblast, donor1	11277-116H8	31.27	23.06	4.30	5.86	1.37	0.59
Osteoblast, donor2	11354-117H4	71.64	38.63	16.15	16.15	5.62	0.70
Osteoblast, donor3	11426-118G4	43.37	35.55	14.40	11.55	2.84	0.53
Pancreatic stromal cells, donor1	11249-116E7	40.26	35.55	13.22	11.54	3.03	1.01
Pericytes, donor1	11491-119E6	12.35	9.46	3.00	1.22	0.56	0.11
Pericytes, donor2	11571-120E5	13.13	11.09	6.56	2.04	1.13	0.23
Pericytes, donor3	11652-122E5	20.14	19.94	8.34	6.31	1.22	0.61
Perineurial Cells, donor1	11499-119F5	47.24	44.08	19.44	12.55	3.05	0.11
Perineurial Cells, donor2	11579-120F4	60.54	35.70	16.29	9.29	2.30	2.21
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	73.31	43.03	18.49	11.79	2.23	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	49.71	20.08	13.71	11.26	2.94	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	48.14	22.39	12.29	7.25	2.59	0.65
Placental Epithelial Cells, donor1	11278-116H9	11.96	20.09	6.46	5.74	1.91	0.48
Placental Epithelial Cells, donor2	11355-117H5	27.72	34.38	8.87	2.22	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	20.42	20.42	6.48	4.32	1.18	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	28.80	21.84	8.86	5.06	1.90	1.27
Preadipocyte - breast, donor1	11467-119B9	44.27	46.33	15.94	12.76	4.13	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	90.46	92.28	33.68	30.15	8.22	1.57
Preadipocyte - breast, donor2	11328-117E5	52.23	40.53	14.63	7.43	3.38	1.35
Preadipocyte - omental, donor1	11468-119C1	49.66	52.43	20.46	14.60	4.48	1.81
Preadipocyte - omental, donor2	11329-117E6	64.60	58.05	28.37	14.84	2.18	2.18
Preadipocyte - omental, donor3	11403-118D8	55.15	53.15	20.20	13.75	5.73	1.15
Preadipocyte - perirenal, donor1	11469-119C2	38.39	31.50	10.83	2.95	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	34.09	28.56	7.06	4.91	3.07	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	57.37	40.37	11.86	10.80	2.83	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	44.96	28.61	13.11	9.20	3.24	1.36
Preadipocyte - visceral, donor1	11280-116I2	66.69	47.04	15.74	11.27	3.82	1.49
Preadipocyte - visceral, donor2	11357-117H7	40.50	29.45	9.20	5.98	1.38	0.92
Preadipocyte - visceral, donor3	11429-118G7	40.54	31.87	10.45	6.48	3.24	1.36
Prostate Epithelial Cells (polarized), donor1	11253-116F2	74.97	70.15	33.04	22.48	6.79	3.92
Prostate Epithelial Cells, donor2	11331-117E8	35.21	33.72	12.73	9.61	5.42	1.22
Prostate Epithelial Cells, donor3	11404-118D9	11.33	17.45	18.00	14.27	5.70	0.55
Prostate Stromal Cells, donor1	11254-116F3	39.18	30.98	11.28	9.57	2.85	0.80
Prostate Stromal Cells, donor2	11332-117E9	32.09	26.72	10.40	6.63	2.15	0.18
Prostate Stromal Cells, donor3	11405-118E1	30.55	25.76	12.62	6.88	2.40	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.60	18.25	7.30	4.38	2.92	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	36.11	43.74	19.75	11.51	4.51	0.14
Renal Epithelial Cells, donor1	11517-119H5	6.59	14.71	4.06	3.04	2.54	0.00
Renal Epithelial Cells, donor2	11597-120H4	13.52	14.23	2.85	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	40.12	44.67	22.44	13.23	3.60	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	18.38	6.81	4.09	2.72	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	26.14	16.71	8.62	5.93	3.91	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	44.40	31.53	13.32	10.66	5.55	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	5.99	0.00	2.66	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	22.01	18.05	6.60	3.30	1.76	0.44
Renal Mesangial Cells, donor2	11598-120H5	21.94	15.67	10.66	4.39	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	5.83	6.94	2.77	1.39	1.11	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	36.24	54.49	15.84	9.13	3.49	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	12.65	21.93	7.59	5.48	2.95	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	16.58	14.85	5.98	6.17	1.54	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	24.37	30.60	18.15	13.22	2.59	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	27.00	28.71	10.23	6.25	1.14	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	7.20	5.15	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	24.34	23.08	20.83	7.28	3.01	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	74.03	79.78	36.62	29.93	4.01	3.21
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	15.19	43.78	7.15	8.04	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	30.82	98.52	14.31	12.66	6.05	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	22.04	62.07	8.70	12.76	2.32	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	47.59	57.21	15.47	8.32	1.95	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	39.23	41.21	15.00	9.33	1.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	56.66	60.90	17.40	9.26	2.34	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	70.21	73.43	19.35	11.04	2.60	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	37.53	47.43	14.10	8.39	2.80	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	48.08	49.00	14.33	11.33	2.31	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	43.26	57.09	14.38	9.17	2.88	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	37.21	41.15	9.38	7.56	1.51	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	51.25	49.10	13.08	9.50	1.43	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	50.21	64.13	14.35	8.61	2.15	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	39.81	42.93	13.31	7.19	2.79	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	40.27	48.24	16.15	7.74	2.88	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	46.07	73.22	13.00	8.60	2.29	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	34.28	41.08	12.48	7.64	1.96	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	70.65	64.83	18.98	12.40	3.76	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	42.33	59.45	16.72	6.90	2.12	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	37.18	39.91	13.82	9.73	1.65	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	44.11	56.14	13.56	12.03	3.25	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	45.49	57.88	12.82	9.18	2.24	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	33.36	42.33	14.30	6.73	2.24	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	37.43	46.14	15.38	7.18	1.54	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	41.21	53.06	13.49	6.02	2.01	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	33.48	40.35	14.47	8.34	2.58	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	40.97	48.62	13.83	9.81	1.48	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	59.91	85.15	13.21	5.90	2.59	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	41.67	40.67	13.69	10.91	2.58	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	37.65	53.78	15.20	9.82	3.27	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	45.20	66.98	16.17	9.12	2.70	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	42.03	38.27	15.04	5.97	1.33	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	40.52	45.54	15.25	9.82	3.13	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	54.78	67.97	17.50	10.09	2.42	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	31.33	37.98	12.94	10.73	3.24	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	37.98	56.30	16.97	11.95	2.31	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	49.69	75.65	13.58	10.83	3.78	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	35.12	34.16	14.68	9.33	1.78	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	37.43	38.74	13.79	9.69	4.10	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	51.13	57.44	10.91	5.62	2.39	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	40.24	48.83	14.50	9.77	1.63	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	36.25	43.98	11.99	10.93	4.00	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	41.48	48.25	12.17	5.53	2.90	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	40.48	50.24	13.57	7.62	1.90	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	47.56	52.60	14.31	12.09	3.02	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	46.33	59.24	15.54	7.82	3.20	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.94	48.21	15.37	9.43	1.05	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	33.55	34.45	8.46	11.18	1.51	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.61	65.23	16.28	7.83	1.96	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	48.91	62.15	18.05	12.66	2.47	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	38.33	51.72	10.95	7.91	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	47.62	63.90	17.78	7.84	1.51	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	47.95	70.12	27.14	11.99	3.39	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	39.54	58.71	20.07	14.68	4.49	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	48.53	64.00	19.84	10.04	3.07	3.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	34.36	39.91	14.73	12.38	1.49	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	42.67	49.88	18.63	11.42	6.61	0.60
Schwann Cells, donor1	11498-119F4	10.91	8.46	3.57	2.44	0.56	0.00
Schwann Cells, donor2	11578-120F3	20.41	17.01	6.80	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	46.45	28.26	10.95	9.42	2.41	0.44
Sebocyte, donor1	11220-116B5	33.96	52.04	15.89	12.60	1.10	0.55
Sebocyte, donor2	11301-117B5	19.76	25.74	6.89	5.51	3.22	0.46
Sebocyte, donor3	11378-118B1	17.52	14.22	8.45	2.89	1.03	0.82
Sertoli Cells, donor1	11255-116F4	48.04	41.41	21.54	8.28	3.31	0.00
Sertoli Cells, donor2	11333-117F1	36.72	25.42	8.47	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	27.45	25.60	11.96	8.27	2.55	0.35
Skeletal Muscle Cells, donor2	11358-117H8	10.12	11.57	6.51	0.72	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	17.56	23.41	5.85	1.67	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	27.49	23.25	9.74	8.33	3.14	0.16
Skeletal Muscle Cells, donor5	11455-119A6	30.03	22.30	9.66	6.24	3.72	0.30
Skeletal Muscle Cells, donor6	11459-119B1	27.09	21.08	10.00	6.93	4.46	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	46.50	34.78	14.49	11.97	3.78	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.82	27.97	10.56	8.42	2.57	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	36.51	27.68	9.33	8.83	2.98	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	40.53	42.29	13.99	11.71	3.03	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.75	13.75	5.79	2.90	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	22.29	18.58	8.94	3.72	2.61	0.41
Skin - palm, donor1	10286-104F7	8.06	13.43	10.74	2.69	10.74	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.71	19.32	7.21	7.21	3.89	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	41.71	67.88	9.81	9.00	6.54	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.15	16.36	4.41	4.02	1.30	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	33.92	39.62	19.04	15.15	2.92	2.22
Small Airway Epithelial Cells, donor2	11334-117F2	22.51	23.21	10.69	7.17	4.08	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	100.44	88.60	31.29	18.61	7.19	2.33
Small Airway Epithelial Cells, donor3	11406-118E2	18.89	24.58	19.04	11.84	3.97	0.67
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.95	4.94	1.23	1.23	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	127.62	151.63	55.58	32.02	13.34	3.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	26.45	29.98	11.17	5.88	4.70	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.31	25.64	9.50	7.29	1.33	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	27.56	21.66	5.12	5.51	1.97	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	33.22	31.68	8.50	3.86	4.64	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	44.03	20.02	6.00	4.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	47.51	46.31	14.11	10.51	2.79	2.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	49.21	35.91	17.07	12.86	4.88	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	41.74	35.85	15.11	9.47	4.61	1.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	42.33	31.58	10.42	7.81	2.28	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	45.48	41.64	16.54	6.79	2.36	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	25.34	23.35	8.11	6.41	1.85	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.46	10.09	3.09	3.74	1.14	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	24.66	27.70	10.66	8.83	3.35	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	41.42	35.61	12.63	9.34	2.78	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	18.36	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	29.09	22.41	10.49	4.77	1.43	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	29.35	28.31	8.26	7.08	1.33	1.18
Smooth Muscle Cells - Colonic, donor2	11320-117D6	27.12	27.77	7.96	5.81	1.51	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	30.86	24.14	8.50	4.72	1.57	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	27.69	27.38	7.89	6.65	2.01	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	15.09	14.01	4.31	3.23	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	25.70	21.82	7.77	4.78	2.39	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	11.27	11.27	2.39	2.73	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	30.63	30.94	11.94	6.75	1.33	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	45.39	39.95	21.34	19.22	6.74	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	65.54	60.98	20.25	6.37	3.64	1.82
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	30.19	19.32	5.43	4.83	4.23	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	45.57	42.39	11.39	9.80	3.71	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	52.33	43.01	15.18	9.72	3.46	1.60
Smooth Muscle Cells - Prostate, donor2	11335-117F3	33.18	27.80	11.14	9.14	2.88	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	39.06	26.89	10.65	9.64	1.27	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	45.99	36.34	11.01	11.46	2.41	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	21.00	16.50	8.25	5.25	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	19.38	7.75	3.88	5.17	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	39.07	26.51	10.70	15.35	1.40	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	26.76	25.75	12.12	7.57	1.51	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	39.17	32.28	13.16	10.34	4.39	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.96	10.62	4.13	4.72	1.18	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	34.82	30.16	10.66	9.58	2.17	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.02	22.42	9.34	5.61	1.87	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	29.22	31.95	13.53	9.50	3.02	1.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	20.91	21.16	7.65	5.86	1.27	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	22.19	15.04	5.83	5.64	1.50	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	37.31	33.54	12.58	8.80	2.66	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	37.79	33.68	16.09	9.05	2.35	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.67	2.38	2.38	2.38	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	32.05	33.03	11.99	6.12	2.45	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	36.68	33.36	15.02	5.97	3.09	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	26.04	21.07	9.07	4.10	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	25.27	31.49	7.00	7.77	1.94	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	22.74	26.71	9.78	8.20	3.17	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	25.29	39.05	10.41	7.44	2.60	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.92	34.86	6.47	11.50	3.23	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.90	23.28	3.97	6.53	2.84	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	28.75	40.17	5.51	9.06	2.76	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	25.14	30.22	5.33	5.84	1.52	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	20.37	24.76	6.79	7.99	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	15.47	15.05	5.43	7.11	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	18.79	26.13	5.96	4.58	1.38	0.92
Synoviocyte, donor1	11291-117A4	32.65	36.53	15.15	11.78	2.19	1.68
Synoviocyte, donor2	11368-117I9	40.06	30.68	14.42	8.72	1.84	0.84
Synoviocyte, donor3	11440-118H9	37.09	37.76	14.75	9.83	2.46	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	16.44	17.51	6.07	2.86	1.43	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	3.96	3.96	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.80	9.72	1.85	0.93	1.39	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	19.21	22.58	10.75	7.24	2.58	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	15.85	18.56	7.34	5.03	2.32	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	16.03	5.15	3.44	3.44	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	75.17	89.19	40.47	32.85	3.57	2.46
Urethra, donor2	10319-105A4	14.39	16.19	23.38	30.57	7.19	0.00
Urothelial Cells, donor1	11520-119H8	17.80	27.10	10.10	3.98	0.80	0.80
Urothelial Cells, donor2	11600-120H7	10.41	11.62	6.01	2.00	4.01	0.40
Urothelial Cells, donor3	11681-122H7	6.42	14.90	6.65	2.75	0.23	0.00
Urothelial cells, donor0	11216-116B1	30.54	61.96	27.86	14.71	5.35	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	106.77	73.85	41.82	22.24	5.34	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	107.22	70.05	28.59	20.01	8.58	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	54.76	41.07	28.07	19.85	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	63.70	32.02	24.79	17.91	2.07	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	72.63	48.23	27.31	17.43	2.32	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	67.68	66.64	37.48	14.58	6.25	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	91.78	56.90	26.62	14.68	3.67	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	45.64	26.47	16.43	13.69	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	35.28	30.84	11.72	8.64	4.32	0.99
Wilms' tumor cell line:HFWT	10597-108E3	2.64	7.04	9.68	7.04	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	12.57	15.08	10.61	5.87	5.31	0.28
achilles tendon, donor2	10292-104G4	16.53	16.53	8.27	8.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	124.16	44.87	13.51	9.69	3.82	3.06
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	44.81	23.68	10.91	5.80	3.02	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	36.80	24.69	10.09	11.75	2.61	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	69.93	38.91	10.61	8.98	3.54	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	71.96	32.32	17.15	10.96	3.94	2.53
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	88.82	41.66	15.44	10.79	3.60	2.75
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	54.44	23.95	7.35	7.08	5.17	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	84.60	29.52	8.81	5.29	1.76	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	214.80	110.67	26.14	21.64	7.76	4.49
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	79.60	40.77	10.87	12.43	6.99	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	84.27	46.00	14.35	11.22	4.42	1.84
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	39.01	19.50	11.70	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	66.00	36.72	9.99	7.90	3.95	3.25
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	52.30	38.58	14.24	10.36	3.11	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	43.84	34.48	11.98	9.64	3.80	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	30.67	30.21	12.08	6.97	1.86	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	118.85	107.34	37.01	23.03	8.23	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	22.41	22.41	3.68	6.45	3.99	1.53
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	71.26	64.01	20.48	14.08	7.25	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	71.88	73.09	22.44	15.77	6.37	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	72.69	63.31	21.42	13.24	4.81	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	56.58	34.08	11.81	13.81	4.01	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	21.35	21.01	8.01	10.67	3.34	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	13.01	7.43	5.57	18.58	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	182.68	59.51	21.85	19.21	7.53	13.56
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	40.56	19.63	3.05	6.98	3.05	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	56.23	7.50	5.62	3.75	11.25	3.75
adenocarcinoma cell line:IM95m	10796-110I4	18.37	23.55	13.89	9.18	2.59	0.00
adipose tissue, adult, pool1	10010-101C1	41.26	26.53	16.44	13.50	3.41	1.09
adipose, donor1	10184-103D4	77.41	29.32	9.97	9.38	4.69	4.69
adipose, donor2	10185-103D5	24.33	12.17	6.49	7.70	0.41	2.43
adipose, donor3	10186-103D6	24.78	14.16	10.07	13.34	3.27	1.36
adipose, donor4	10187-103D7	36.40	20.80	19.94	13.87	0.87	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	22.41	29.20	20.04	20.20	12.15	0.16
adrenal gland, adult, pool1	10081-102A9	32.74	32.74	40.01	32.74	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	40.29	18.01	10.67	7.34	1.73	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	30.01	33.59	13.22	10.36	2.14	1.43
amniotic membrane cells, donor1	12235-129G3	52.63	55.18	35.01	29.91	5.56	1.16
amniotic membrane cells, donor2	12236-129G4	60.86	61.20	32.12	23.33	5.75	2.70
amniotic membrane cells, donor3	12237-129G5	35.06	38.00	33.88	33.29	9.13	0.59
amygdala - adult, donor10196	10167-103B5	16.60	26.09	20.16	29.64	10.67	1.19
amygdala, adult, donor10252	10151-102I7	34.47	32.85	36.30	22.91	5.88	0.81
amygdala, newborn, donor10223	10360-105E9	22.27	29.69	16.78	28.08	7.10	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	33.62	22.66	9.04	10.19	3.44	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	51.85	37.51	13.24	7.94	3.31	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	64.14	40.08	14.03	14.03	5.01	0.67
aorta, adult, pool1	10052-101G7	33.15	31.19	27.07	31.58	8.83	0.98
appendix, adult	10189-103D9	46.57	31.44	15.52	14.75	5.05	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	74.29	93.89	46.78	26.83	9.29	1.72
artery, adult	10190-103E1	13.59	17.66	16.30	12.23	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	57.80	68.67	11.15	6.37	2.03	1.30
b cell line:RPMI1788	10427-106D4	49.22	22.31	7.14	4.01	1.04	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	40.78	39.95	18.31	8.60	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	27.39	27.69	10.72	10.22	2.78	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	24.44	31.47	15.23	9.21	1.51	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	34.67	20.69	18.45	8.39	5.03	0.00
bladder, adult, pool1	10011-101C2	27.49	22.71	14.88	14.56	2.61	0.54
blood, adult, pool1	10053-101G8	31.00	11.07	13.29	8.86	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	25.69	19.70	9.42	4.28	0.86	0.00
bone marrow, adult	10192-103E3	50.61	49.26	18.22	12.82	3.37	0.67
brain, adult, donor1	10084-102B3	26.65	15.38	17.43	25.63	5.13	0.00
brain, adult, pool1	10012-101C3	22.05	20.27	19.82	20.94	5.46	0.56
brain, fetal, pool1	10085-102B4	34.73	40.07	18.70	18.70	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	21.47	17.18	14.54	14.54	8.92	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	23.22	31.33	20.22	17.85	7.11	0.25
breast, adult, donor1	10080-102A8	23.36	25.89	18.94	17.05	7.58	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	34.05	41.92	15.75	16.13	7.37	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	26.90	34.94	14.84	14.22	4.95	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	42.36	27.86	12.89	18.42	8.75	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	47.45	53.26	25.42	30.50	7.50	1.45
carcinoid cell line:NCI-H1770	10703-109H1	40.43	41.37	18.34	14.58	4.70	1.41
carcinoid cell line:NCI-H727	10735-110B6	25.81	37.74	21.77	16.95	6.78	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	10.14	10.14	4.44	4.12	0.95	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	52.70	33.80	14.91	11.45	4.26	0.53
caudate nucleus - adult, donor10196	10177-103C6	32.24	36.84	24.18	42.60	17.27	0.00
caudate nucleus, adult, donor10252	10164-103B2	34.13	36.14	38.15	27.44	6.36	0.17
caudate nucleus, adult, donor10258	10379-105H1	30.57	21.40	29.04	41.26	16.05	0.76
caudate nucleus, newborn, donor10223	10354-105E3	18.68	34.79	20.88	31.86	9.89	1.46
cerebellum - adult, donor10196	10173-103C2	29.13	26.22	34.96	49.53	23.31	0.00
cerebellum, adult, donor10252	10166-103B4	35.23	33.95	36.51	31.17	6.41	0.21
cerebellum, adult, pool1	10083-102B2	26.91	17.25	23.46	16.56	8.62	0.34
cerebellum, newborn, donor10223	10357-105E6	38.19	36.53	12.45	22.42	4.98	0.83
cerebral meninges, adult	10188-103D8	21.43	18.91	17.15	19.41	8.07	0.50
cerebrospinal fluid, donor2	10294-104G6	9.50	8.77	5.85	3.65	2.92	0.00
cervical cancer cell line:D98-AH2	10552-107I3	37.96	27.61	23.44	13.66	3.74	0.14
cervical cancer cell line:ME-180	10553-107I4	38.94	42.42	14.58	8.29	1.49	1.33
cervix, adult, pool1	10013-101C4	46.51	37.17	24.25	19.11	4.93	1.68
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	149.65	133.90	45.84	31.07	10.87	3.20
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	5.23	6.53	1.31	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	41.38	49.09	23.74	18.64	4.72	2.24
choriocarcinoma cell line:SCH	10785-110H2	44.48	54.34	20.70	10.84	6.04	1.48
choriocarcinoma cell line:T3M-3	10618-108G6	20.87	21.11	15.89	16.84	4.27	0.00
chorionic membrane cells, donor1	12238-129G6	49.86	47.87	27.64	23.08	4.84	1.14
chorionic membrane cells, donor2	12239-129G7	60.75	61.25	21.18	10.74	2.19	2.49
chorionic membrane cells, donor3	12240-129G8	54.40	67.59	40.66	20.33	2.20	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	34.33	27.26	8.08	4.04	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	50.71	27.09	16.52	16.52	5.19	2.11
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	64.41	29.35	9.50	5.07	1.90	5.07
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	27.73	8.73	5.14	3.60	2.05	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	30.72	12.58	7.50	2.90	2.66	2.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	32.98	14.46	6.11	4.89	2.04	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	46.52	24.73	11.78	7.07	1.77	2.94
chronic myelogenous leukemia cell line:KU812	10409-106B4	106.86	47.17	10.69	8.08	1.30	3.65
clear cell carcinoma cell line:JHOC-5	10638-108I8	26.29	33.14	13.26	9.37	2.97	0.46
clear cell carcinoma cell line:TEN	10636-108I6	39.21	40.77	22.73	19.26	6.25	0.52
colon carcinoma cell line:CACO-2	10513-107D9	106.16	78.34	36.24	19.22	6.22	2.56
colon carcinoma cell line:COLO-320	10420-106C6	113.64	100.72	36.11	33.07	9.50	2.28
colon, adult, donor1	10082-102B1	47.60	47.60	34.51	33.32	10.71	1.19
colon, adult, pool1	10014-101C5	53.93	50.06	32.20	16.92	3.88	3.88
colon, fetal, donor1	10070-101I7	48.82	45.73	42.02	37.70	9.27	1.24
common myeloid progenitor CMP, donor1	12130-128D6	91.67	13.75	0.00	4.58	4.58	4.58
common myeloid progenitor CMP, donor2	12134-128E1	100.15	75.11	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	28.47	9.77	6.80	5.10	1.27	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	31.09	16.60	6.94	5.43	0.91	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	37.79	20.59	9.17	7.61	2.12	1.41
corpus callosum, adult, pool1	10042-101F6	46.10	50.64	31.62	29.41	9.40	0.22
cruciate ligament, donor2	10295-104G7	20.26	25.12	9.73	10.54	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	32.91	24.88	24.08	13.64	5.62	0.00
diencephalon, adult	10193-103E4	26.64	22.80	20.64	19.68	7.92	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	32.60	14.24	4.82	1.84	1.15	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	40.00	44.62	32.82	18.72	8.46	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.63	17.33	4.81	6.50	5.06	0.24
ductus deferens, adult	10196-103E7	52.33	62.79	35.38	36.38	10.47	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	96.50	92.17	56.17	40.33	14.40	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	73.56	74.30	24.28	30.90	3.68	4.41
dura mater, adult, donor1	10041-101F5	75.07	43.28	24.20	21.97	9.50	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	14.43	13.77	4.22	3.33	1.55	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	29.23	25.22	10.60	8.60	5.02	1.29
embryonic pancreas cell line:1B2C6	10604-108F1	8.02	18.50	3.70	3.08	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	15.14	20.89	13.02	6.05	3.33	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	19.76	21.92	9.57	5.87	3.40	0.62
embryonic pancreas cell line:2C6	10603-108E9	17.08	30.21	6.57	2.63	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	26.15	19.44	11.40	10.06	1.68	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	33.17	45.49	23.92	21.57	3.62	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	47.12	56.77	25.09	14.31	5.47	1.45
epidermoid carcinoma cell line:A431	10426-106D3	66.25	48.80	16.34	11.34	5.11	2.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	31.02	43.11	17.93	11.44	6.27	0.77
epididymis, adult	10197-103E8	46.47	42.28	27.42	25.54	8.37	3.14
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	29.10	34.59	13.66	11.00	3.37	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	23.99	31.07	9.04	9.04	2.75	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	44.82	50.19	17.17	9.30	3.01	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	43.21	40.25	13.98	7.58	2.76	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	49.29	43.58	17.92	7.84	2.91	1.12
esophagus, adult, pool1	10015-101C6	30.26	23.89	15.93	14.97	3.61	1.06
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	43.08	61.62	31.06	31.94	7.14	2.38
eye - muscle inferior rectus, donor1	10272-104E2	19.32	12.07	16.90	12.07	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	10.52	16.83	12.63	2.10	0.00
eye - muscle medial, donor2	10299-104H2	4.46	11.91	7.44	4.46	2.98	0.00
eye - muscle superior, donor2	10297-104G9	16.05	8.03	12.61	18.34	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	7.29	13.12	5.83	0.00	0.00
eye, fetal, donor1	10054-101G9	36.61	35.34	30.00	27.97	5.59	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	35.39	28.08	14.62	8.85	3.72	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	29.20	32.29	7.83	9.73	4.99	0.71
frontal lobe, adult, pool1	10040-101F4	34.06	34.71	33.68	34.90	10.23	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	121.30	146.52	32.43	24.92	6.61	2.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	34.11	34.20	24.14	18.38	6.86	0.27
gall bladder, adult	10198-103E9	42.73	33.56	21.25	18.35	7.48	3.38
gamma delta positive T cells, donor1	11937-126A2	64.42	22.01	9.66	8.05	2.68	0.54
gamma delta positive T cells, donor2	11938-126A3	75.45	23.90	7.47	7.84	1.87	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	53.44	44.36	19.22	10.77	3.59	2.32
gastric adenocarcinoma cell line:MKN45	10612-108F9	87.81	113.92	65.18	35.59	11.41	2.90
gastric cancer cell line:AZ521	10549-107H9	43.28	54.43	29.02	17.87	2.62	1.15
gastric cancer cell line:GSS	10560-108A2	43.93	28.37	12.81	13.73	10.98	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	67.17	115.37	35.18	18.96	5.48	1.37
giant cell carcinoma cell line:LU65	10487-107B1	25.47	54.73	29.49	17.90	5.16	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	33.73	25.75	14.98	14.56	6.86	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	50.38	51.38	22.20	20.20	7.48	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	48.34	39.27	15.41	15.94	3.59	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	51.12	42.41	22.47	12.36	3.23	0.98
glioblastoma cell line:T98G	10485-107A8	55.74	39.51	12.69	10.38	1.99	1.43
glioma cell line:GI-1	10413-106B8	67.95	69.70	24.89	17.87	2.05	1.76
globus pallidus - adult, donor10196	10175-103C4	17.49	16.04	16.76	18.22	10.93	0.00
globus pallidus, adult, donor10252	10161-103A8	38.81	31.98	27.58	17.57	8.54	0.24
globus pallidus, adult, donor10258	10367-105F7	15.06	31.49	12.32	19.17	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	11.72	16.52	10.66	13.86	5.33	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	68.52	12.24	2.45	4.89	2.45	19.58
granulocyte macrophage progenitor, donor2	12135-128E2	109.28	10.93	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	5.23	0.00	5.23	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	16.64	16.96	6.72	3.84	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	46.37	40.86	7.35	5.51	3.21	0.92
hIPS +CCl2, biol_rep2	14384-156C1	50.30	42.07	8.69	5.94	3.66	1.83
hIPS +CCl2, biol_rep3	14385-156C2	61.83	59.26	5.15	7.73	2.58	0.64
hIPS, biol_rep1	14380-156B6	34.49	70.43	0.00	1.44	2.87	0.00
hIPS, biol_rep2	14381-156B7	52.81	46.64	3.43	0.69	4.12	0.69
hIPS, biol_rep3	14382-156B8	32.00	35.31	18.76	26.48	12.14	0.00
hairy cell leukemia cell line:Mo	10712-109I1	28.45	13.22	4.60	5.75	2.30	0.29
heart - mitral valve, adult	10205-103F7	25.11	18.54	15.25	22.72	2.39	0.60
heart - pulmonic valve, adult	10206-103F8	18.30	17.26	12.03	19.09	2.35	1.05
heart - tricuspid valve, adult	10207-103F9	17.49	16.65	10.82	15.82	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	26.12	37.14	24.28	19.79	4.49	0.61
heart, adult, diseased, donor1	10051-101G6	19.16	23.85	19.16	24.27	2.13	0.00
heart, adult, pool1	10016-101C7	28.75	24.38	12.88	17.02	2.07	1.15
heart, fetal, pool1	10046-101G1	42.71	39.02	29.37	22.69	4.52	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	41.34	37.33	14.81	12.96	1.85	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	4.76	4.76	2.38	5.95	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	80.55	46.19	14.47	5.19	1.99	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	85.57	48.55	16.02	6.55	1.70	3.40
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	85.69	53.36	16.47	4.95	2.43	4.24
hepatoma cell line:Li-7	10484-107A7	29.36	26.14	9.01	4.78	1.00	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	75.27	40.00	14.77	6.73	2.81	1.61
hippocampus - adult, donor10196	10169-103B7	29.34	38.80	28.39	22.71	17.03	0.00
hippocampus, adult, donor10252	10153-102I9	33.06	32.86	28.78	20.21	6.94	0.61
hippocampus, adult, donor10258	10374-105G5	20.42	37.84	13.44	9.46	9.96	0.00
hippocampus, newborn, donor10223	10363-105F3	9.52	13.75	8.81	18.68	5.99	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	93.99	51.27	12.82	9.16	5.49	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	43.79	31.61	9.62	4.12	3.34	2.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	53.57	29.71	4.32	6.09	3.30	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	33.27	15.79	3.38	5.07	3.95	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	39.25	12.91	8.78	9.81	3.87	2.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	33.79	18.98	7.97	6.83	1.52	2.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	23.94	16.64	4.67	8.76	2.92	3.50
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	28.01	10.99	8.19	10.34	1.29	1.94
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	25.02	19.60	6.26	7.92	3.75	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	37.89	30.31	8.52	7.58	2.84	3.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	35.68	19.61	9.48	11.57	2.89	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	49.15	33.67	8.08	8.08	2.02	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	54.46	24.57	5.79	2.97	2.35	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	50.11	26.53	5.40	5.40	6.88	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	77.68	45.38	5.24	7.85	1.75	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	52.69	23.48	6.68	7.45	3.44	2.10
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	45.35	18.32	6.98	5.67	2.18	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	41.48	26.49	6.00	7.50	3.50	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	27.88	12.06	7.16	10.55	3.96	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	35.47	20.01	8.64	15.46	9.55	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	23.81	16.91	8.77	9.08	4.39	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	41.64	22.54	10.12	11.43	3.27	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	35.42	29.61	10.16	7.26	1.74	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	37.66	25.11	9.57	12.55	1.79	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	50.80	25.13	7.76	7.02	2.77	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	54.77	33.95	9.13	5.42	2.00	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	60.43	44.10	7.76	7.76	2.86	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.25	24.29	9.51	10.56	7.75	2.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	37.38	23.12	6.65	5.38	2.85	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	37.83	23.91	8.17	6.05	2.42	2.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	23.27	16.03	8.27	7.76	4.14	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	27.23	19.26	10.63	9.96	3.98	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	21.81	14.11	4.36	7.18	2.05	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	31.70	24.80	8.44	6.90	1.02	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	43.92	34.83	12.87	11.36	4.54	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	34.28	25.54	5.38	12.43	3.70	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	51.92	27.53	4.59	5.80	1.69	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	61.06	43.23	4.46	5.79	2.23	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	44.39	33.17	7.32	6.83	1.95	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	41.56	21.39	6.11	4.89	2.44	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	182.18	113.86	26.03	6.51	16.27	32.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	49.64	34.42	7.61	6.29	4.30	4.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	21.89	18.61	2.74	5.47	4.38	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.27	11.94	11.58	9.05	2.17	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	20.28	18.86	6.41	6.05	2.14	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	26.25	27.45	3.58	5.97	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	47.40	35.35	13.68	10.43	2.84	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	23.98	19.94	5.12	9.43	1.35	0.54
immature langerhans cells, donor1	11904-125F5	51.34	26.39	7.75	7.02	7.02	2.66
immature langerhans cells, donor2	11905-125F6	34.06	20.60	7.13	10.30	2.38	3.17
insula, adult, pool1	10039-101F3	39.46	37.19	36.15	33.31	10.41	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	48.45	57.88	17.56	8.45	1.30	1.30
kidney, adult, pool1	10017-101C8	67.49	65.28	28.84	23.53	5.51	1.20
kidney, fetal, pool1	10045-101F9	61.26	64.51	34.66	25.68	7.29	1.34
large cell lung carcinoma cell line:IA-LM	10509-107D5	51.13	52.69	27.55	18.04	5.54	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	22.67	17.14	9.95	8.57	2.49	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	7.52	9.91	4.95	2.57	1.47	0.18
left atrium, adult, donor1	10079-102A7	29.97	26.15	22.34	20.70	4.90	0.54
left ventricle, adult, donor1	10078-102A6	19.21	11.12	15.17	20.73	4.55	0.51
leiomyoblastoma cell line:G-402	10721-110A1	21.62	21.34	7.11	4.65	2.46	1.37
leiomyoma cell line:10964C	10569-108B2	15.81	19.04	6.83	7.18	3.95	1.44
leiomyoma cell line:15242A	10570-108B3	30.43	27.17	10.87	8.70	3.80	0.54
leiomyoma cell line:15425	10571-108B4	30.84	24.28	14.81	7.04	3.40	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	19.05	6.35	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	21.96	15.68	9.41	8.36	4.18	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	49.23	17.59	5.90	2.95	1.53	2.24
liposarcoma cell line:KMLS-1	10782-110G8	51.86	62.95	21.09	17.18	3.12	0.62
liposarcoma cell line:SW 872	10726-110A6	91.38	104.66	35.09	25.59	6.70	1.34
liver, adult, pool1	10018-101C9	94.81	108.26	36.95	18.96	4.70	6.97
liver, fetal, pool1	10086-102B5	40.45	47.98	31.98	20.70	8.47	0.94
locus coeruleus - adult, donor10196	10182-103D2	19.69	20.85	16.33	19.10	6.12	0.15
locus coeruleus, adult, donor10252	10165-103B3	30.45	27.31	28.24	21.96	4.61	0.18
locus coeruleus, adult, donor10258	10375-105G6	21.72	24.55	10.72	21.16	9.87	1.41
locus coeruleus, newborn, donor10223	10362-105F2	33.65	45.43	18.93	20.61	5.89	0.84
lung adenocarcinoma cell line:A549	10499-107C4	42.21	41.66	15.09	6.92	2.21	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	22.06	20.68	8.96	10.34	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	23.07	30.32	14.37	9.10	3.95	0.92
lung, adult, pool1	10019-101D1	42.29	44.65	20.55	17.25	4.49	1.77
lung, fetal, donor1	10068-101I5	100.18	126.72	46.81	27.40	6.85	2.85
lung, right lower lobe, adult, donor1	10075-102A3	64.15	68.27	34.82	34.37	11.00	2.75
lymph node, adult, donor1	10077-102A5	79.52	44.02	14.67	16.57	4.73	2.37
lymphangiectasia cell line:DS-1	10727-110A7	114.63	67.95	27.18	13.81	3.95	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	74.10	25.20	7.09	3.77	0.30	5.28
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	35.68	29.73	16.99	5.95	2.55	0.85
mature adipocyte, donor1	12231-129F8	29.30	19.09	5.77	7.55	1.33	1.33
mature adipocyte, donor2	12232-129F9	34.24	21.38	12.87	10.38	2.28	2.08
mature adipocyte, donor3	12233-129G1	28.92	22.76	12.80	11.62	2.37	1.66
mature adipocyte, donor4	12234-129G2	36.06	26.85	10.27	9.48	1.05	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	33.12	46.46	24.54	15.25	6.67	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	29.33	19.18	32.71	25.94	13.54	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	32.00	31.08	33.84	20.78	4.05	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	21.60	29.54	18.74	22.56	6.67	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	31.13	29.43	7.68	17.49	7.68	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	26.66	25.48	24.47	27.17	11.64	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	33.96	30.56	31.41	23.77	4.88	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	46.23	13.48	13.48	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	114.83	43.06	0.00	71.77	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	20.10	26.92	12.56	22.97	7.18	0.00
medulla oblongata - adult, donor10196	10174-103C3	30.50	52.57	20.77	29.85	5.84	0.65
medulla oblongata, adult, donor10252	10155-103A2	40.25	41.49	31.58	20.43	4.80	0.31
medulla oblongata, adult, pool1	10038-101F2	38.04	35.18	28.73	27.51	5.22	0.33
medulla oblongata, newborn, donor10223	10361-105F1	26.73	42.70	14.23	21.53	4.86	0.00
medulloblastoma cell line:D283 Med	10838-111E1	45.39	40.96	26.57	27.23	12.40	0.66
medulloblastoma cell line:ONS-76	10759-110E3	14.06	13.69	6.48	6.73	3.06	0.24
melanoma cell line:COLO 679	10514-107E1	32.63	30.62	17.11	11.93	3.59	1.87
melanoma cell line:G-361	10465-106H6	21.17	23.07	9.77	11.67	1.90	0.00
meningioma cell line:HKBMM	10691-109F7	22.97	23.70	11.94	5.79	2.71	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	56.39	41.41	16.74	6.17	7.05	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	36.81	36.81	15.03	12.18	4.67	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	82.70	50.63	17.64	9.82	3.07	1.99
mesenchymal precursor cell - adipose, donor2	11748-123G2	43.81	31.81	10.73	6.91	1.09	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	50.11	48.45	10.35	5.38	2.07	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	40.46	37.93	13.77	5.62	1.40	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	42.37	36.59	14.06	5.20	0.96	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	43.03	42.34	15.96	8.33	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	37.07	39.82	14.25	8.07	1.72	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	36.58	37.84	17.25	6.56	2.30	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	53.45	37.27	10.08	6.23	1.99	1.46
mesenchymal precursor cell - cardiac, donor4	11755-123G9	63.33	42.00	14.72	9.32	2.84	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	63.45	44.39	15.51	7.82	2.42	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	38.86	44.79	12.52	9.55	2.31	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	51.75	34.59	10.24	6.37	2.21	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	42.94	41.19	14.66	8.73	1.75	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	51.25	39.61	24.91	8.57	2.04	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	26.96	37.74	8.27	7.91	2.52	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	32.79	30.31	13.97	7.97	2.28	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	27.13	34.20	13.91	9.12	2.28	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	65.03	64.19	23.08	12.59	3.78	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	58.88	37.66	11.81	8.97	1.94	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	47.62	40.88	15.84	4.99	1.31	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	34.98	41.60	14.73	9.94	1.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	33.48	28.90	8.87	10.87	2.58	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	34.94	30.73	7.16	10.10	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	40.19	26.03	6.85	7.76	4.11	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	51.41	36.07	10.49	11.00	2.05	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	43.19	32.46	12.56	8.64	3.40	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	45.90	30.19	13.56	6.47	4.01	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	35.30	28.24	12.00	7.30	2.82	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	41.63	32.49	12.18	9.14	1.35	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	46.37	31.83	11.00	6.68	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	38.92	36.61	7.88	8.34	2.32	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	58.84	33.17	15.00	10.67	4.04	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	47.52	35.70	12.72	8.25	3.79	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	46.15	34.85	14.42	9.37	3.61	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	46.20	29.33	5.87	8.07	2.20	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	38.26	32.56	10.74	9.06	1.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	38.89	33.16	7.78	9.83	3.68	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	47.25	32.65	12.03	8.59	6.01	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	35.55	8.20	10.94	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	15.49	0.00	0.00	5.16	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	41.25	31.83	9.09	6.82	4.87	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	37.83	33.46	7.27	11.64	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	33.58	25.59	10.13	8.53	3.73	4.26
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	23.72	20.44	6.54	4.09	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.60	22.55	5.05	10.50	1.17	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	20.99	2.10	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	39.74	28.81	9.93	10.93	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	23.84	0.00	0.00	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	32.02	26.68	10.08	4.74	3.56	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	46.30	15.84	10.97	2.44	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	39.90	29.14	8.87	10.77	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	33.46	22.76	4.48	5.17	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	25.79	4.30	2.15	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	31.93	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	41.33	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	38.71	20.37	6.11	3.67	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	42.11	27.01	2.38	5.56	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	26.53	23.58	5.31	3.54	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	31.48	20.57	5.61	2.81	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	34.75	26.73	5.35	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	27.20	26.02	3.55	1.18	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	20.54	5.14	2.57	2.57	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	32.35	26.85	6.20	5.51	2.07	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	22.27	25.24	5.94	4.45	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	25.79	25.79	7.85	6.73	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	19.08	27.99	8.90	6.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	24.98	32.24	8.46	4.43	1.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	26.17	10.90	6.54	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	17.74	6.34	8.87	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	38.84	43.09	13.35	12.14	1.21	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	36.15	22.59	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	34.59	36.24	11.53	11.53	1.65	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	31.35	30.76	9.13	8.73	1.59	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	20.77	20.12	9.09	6.49	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	29.54	18.34	8.15	10.19	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	24.76	18.57	9.28	1.55	1.55	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	18.19	33.31	16.54	7.56	0.94	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	35.91	25.72	8.11	5.56	0.93	2.09
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	8.55	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	23.74	13.56	2.77	2.47	0.21	0.41
mesothelioma cell line:Mero-25	10850-111F4	25.65	18.61	4.09	4.09	1.82	0.45
mesothelioma cell line:Mero-41	10851-111F5	22.98	28.36	9.78	8.80	2.93	0.73
mesothelioma cell line:Mero-48a	10852-111F6	46.50	44.29	19.04	13.73	6.20	1.33
mesothelioma cell line:Mero-82	10853-111F7	28.65	23.92	6.31	6.04	1.58	0.26
mesothelioma cell line:Mero-83	10854-111F8	40.00	32.51	7.66	5.96	1.02	0.68
mesothelioma cell line:Mero-84	10855-111F9	42.47	34.88	9.35	4.04	2.53	1.77
mesothelioma cell line:Mero-95	10856-111G1	40.79	28.16	8.70	6.42	2.28	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	35.12	37.77	15.57	17.39	7.62	0.99
mesothelioma cell line:NCI-H226	10846-111E9	44.70	38.91	6.33	3.80	1.45	1.81
mesothelioma cell line:NCI-H2452	10848-111F2	25.96	30.24	13.49	10.08	1.37	0.34
mesothelioma cell line:NCI-H28	10845-111E8	38.42	40.21	15.01	10.18	5.34	0.76
mesothelioma cell line:No36	10857-111G2	15.98	16.96	8.16	8.16	1.30	0.98
mesothelioma cell line:ONE58	10858-111G3	17.61	23.03	7.32	4.06	1.63	1.35
migratory langerhans cells, donor1	11901-125F2	24.57	22.65	6.14	4.22	1.54	0.00
migratory langerhans cells, donor2	11902-125F3	33.34	25.89	7.08	5.98	1.71	0.61
migratory langerhans cells, donor3	11903-125F4	53.66	27.82	8.08	7.36	1.44	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	20.89	29.71	12.41	12.73	1.63	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.85	36.24	10.81	4.45	2.12	2.12
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.95	36.17	20.73	17.97	6.91	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	33.11	23.60	6.85	6.28	1.90	2.09
myelodysplastic syndrome cell line:SKM-1	10772-110F7	88.70	43.06	16.26	9.05	3.88	0.74
myeloma cell line:PCM6	10474-106I6	55.54	47.04	17.00	10.28	2.57	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	11.16	2.54	2.54	1.52	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	57.27	46.29	15.69	10.79	3.53	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	17.27	23.84	22.28	13.26	4.79	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	15.52	23.46	20.08	13.16	4.63	0.29
nasal epithelial cells, donor2	12227-129F4	33.12	29.26	16.56	12.70	2.21	0.00
neuroblastoma cell line:CHP-134	10508-107D4	57.52	41.41	17.25	12.19	2.07	1.15
neuroblastoma cell line:NB-1	10539-107G8	77.08	51.82	27.50	16.09	5.99	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	99.54	98.70	25.73	11.81	3.80	2.11
neuroblastoma cell line:NH-12	10555-107I6	55.91	31.49	19.57	13.42	2.80	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.63	22.06	14.00	9.73	3.80	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	37.38	31.99	21.38	16.00	8.08	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	33.41	19.12	7.04	3.82	1.01	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	13.35	15.26	8.26	6.99	2.54	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	28.75	32.21	11.18	5.86	1.86	0.53
neutrophil PMN, donor1	12133-128D9	133.87	14.87	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	185.93	79.68	39.84	26.56	0.00	53.12
neutrophil PMN, donor3	12141-128E8	198.88	47.35	18.94	56.82	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	101.13	53.95	21.65	12.68	3.55	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	54.43	36.02	28.82	12.81	2.40	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	48.09	43.92	18.60	16.03	5.45	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	36.26	34.16	12.61	5.52	1.58	1.31
nucleus accumbens, adult, pool1	10037-101F1	35.34	36.46	35.34	37.68	9.00	0.19
occipital cortex - adult, donor10196	10172-103C1	30.91	43.27	35.03	30.91	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	37.57	29.52	29.79	17.44	3.49	0.00
occipital cortex, newborn, donor10223	10355-105E4	25.84	23.29	9.10	20.02	4.73	0.73
occipital lobe, adult, donor1	10076-102A4	38.57	28.86	32.28	35.42	12.33	0.52
occipital lobe, fetal, donor1	10073-102A1	53.64	52.35	31.75	36.47	12.01	1.72
occipital pole, adult, pool1	10036-101E9	27.52	25.62	23.02	21.05	6.31	0.24
olfactory region, adult	10195-103E6	31.52	21.59	23.12	25.41	5.92	0.38
optic nerve, donor1	10277-104E7	24.01	10.01	18.01	14.01	2.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	84.18	102.06	32.01	17.31	5.92	3.30
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	72.40	70.34	38.61	18.41	7.01	1.79
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	45.38	46.90	10.67	7.62	3.22	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	67.80	54.52	20.33	9.59	2.66	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	35.28	38.51	12.05	12.05	2.65	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	25.23	21.49	12.15	6.54	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	52.17	58.10	19.30	11.03	4.67	0.85
ovary, adult, pool1	10020-101D2	28.83	33.89	18.34	20.70	4.63	1.40
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	18.52	17.23	7.15	5.68	2.57	0.18
pancreas, adult, donor1	10049-101G4	78.07	80.89	46.09	31.98	7.53	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	23.76	28.23	12.86	13.70	2.24	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	25.38	28.79	13.80	11.24	3.75	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	40.73	46.86	20.53	14.90	2.65	0.99
paracentral gyrus, adult, pool1	10035-101E8	37.80	34.60	32.95	28.19	7.60	0.18
parietal cortex, adult, donor10258	10373-105G4	19.82	39.64	24.22	21.29	11.01	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	20.69	27.27	28.21	11.29	0.00
parietal lobe, adult, donor10252	10157-103A4	28.79	27.36	31.07	21.38	4.28	0.29
parietal lobe, adult, pool1	10034-101E7	31.37	34.90	32.96	34.72	7.14	0.18
parietal lobe, fetal, donor1	10072-101I9	83.41	70.80	35.88	24.25	6.79	0.00
parietal lobe, newborn, donor10223	10356-105E5	24.67	22.81	13.09	19.81	4.86	0.37
parotid gland, adult	10199-103F1	62.28	93.12	59.20	68.45	19.12	0.62
penis, adult	10200-103F2	33.30	25.24	15.58	13.43	2.15	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	8.74	7.44	8.00	5.76	1.49	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	61.48	75.76	25.06	13.99	5.54	1.75
pineal gland - adult, donor10196	10179-103C8	21.29	34.83	23.87	23.22	9.68	0.00
pineal gland, adult, donor10252	10160-103A7	67.51	70.47	46.78	41.45	9.48	1.78
pineal gland, adult, donor10258	10377-105G8	47.03	38.25	21.32	26.96	10.03	1.88
pituitary gland - adult, donor10196	10180-103C9	60.71	108.26	41.48	46.54	14.17	0.00
pituitary gland, adult, donor10252	10162-103A9	102.67	146.45	91.21	44.30	13.55	0.52
pituitary gland, adult, donor10258	10378-105G9	71.50	116.62	51.93	40.01	18.73	3.40
placenta, adult, pool1	10021-101D3	64.72	74.71	43.43	44.83	5.27	2.26
plasma cell leukemia cell line:ARH-77	10840-111E3	38.40	16.16	8.21	5.83	2.12	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	79.69	59.61	37.04	31.59	5.76	1.56
pons, adult, pool1	10033-101E6	31.76	29.52	25.39	28.40	7.32	0.34
postcentral gyrus, adult, pool1	10032-101E5	32.69	28.94	27.98	25.37	6.89	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	52.28	4.18	4.18	6.27	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	99.14	22.03	0.00	0.00	5.51	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	35.21	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	26.95	26.22	11.36	6.41	3.06	0.29
prostate cancer cell line:PC-3	10439-106E7	54.09	57.35	25.05	24.14	4.17	1.27
prostate, adult, pool1	10022-101D4	37.55	38.09	25.12	21.40	5.17	1.45
putamen, adult, donor10196	10176-103C5	33.76	35.17	48.63	35.17	10.62	0.47
putamen, adult, donor10252	10152-102I8	23.53	11.76	23.53	15.69	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	45.90	10.93	16.39	5.46	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	20.78	32.13	30.68	32.38	10.87	0.48
putamen, newborn, donor10223	10365-105F5	26.24	47.98	23.99	35.23	8.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	55.28	61.10	22.11	13.96	5.24	2.04
rectum, fetal, donor1	10067-101I4	59.81	40.34	19.47	26.43	5.56	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	50.88	57.24	26.71	14.42	4.03	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	17.81	16.98	2.90	4.97	2.07	0.41
retina, adult, pool1	10030-101E3	51.09	48.90	30.32	29.42	7.36	1.09
retinoblastoma cell line:Y79	10475-106I7	43.91	24.42	10.91	6.24	3.38	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	47.34	31.47	10.57	5.53	3.07	2.83
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	27.00	41.06	16.31	12.09	1.69	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.88	15.91	6.82	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	32.53	20.56	12.14	9.71	4.37	0.65
salivary acinar cells, donor2	11772-123I8	28.09	22.03	13.63	9.50	3.58	0.00
salivary acinar cells, donor3	11773-123I9	14.57	11.25	3.31	8.61	0.00	0.00
salivary gland, adult, pool1	10093-102C3	74.93	113.82	68.63	37.75	17.16	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	27.15	39.96	15.01	11.47	2.70	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	26.92	43.38	22.92	12.46	4.23	0.35
seminal vesicle, adult	10201-103F3	56.61	60.31	44.44	43.38	8.99	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	36.92	42.27	21.38	15.55	6.07	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	44.04	52.34	18.12	13.08	4.03	2.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	56.20	55.19	28.10	14.05	3.01	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	25.12	30.22	22.16	15.31	9.13	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	49.74	41.89	20.34	14.04	5.31	1.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	55.61	55.09	25.16	16.26	6.06	2.45
skeletal muscle - soleus muscle, donor1	10282-104F3	9.22	4.26	6.38	7.80	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	20.63	11.51	11.63	14.15	1.80	1.08
skeletal muscle, fetal, donor1	10066-101I3	46.23	31.16	14.07	21.11	6.03	1.01
skin, adult, donor1	10074-102A2	33.93	27.14	27.14	20.36	33.93	0.00
skin, fetal, donor1	10065-101I2	48.60	44.19	34.09	29.04	4.42	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	67.71	78.04	33.69	21.68	11.67	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	40.35	36.88	15.45	9.77	3.47	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	22.94	35.85	16.58	14.07	4.43	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	41.37	29.83	14.01	11.04	3.13	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	30.88	21.55	29.92	33.62	18.66	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	41.19	54.48	20.92	10.46	2.83	0.65
small intestine, adult, pool1	10024-101D6	81.46	96.15	65.34	43.48	9.20	4.18
small intestine, fetal, donor1	10064-101I1	81.82	92.63	49.88	37.35	8.35	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	48.73	51.29	25.65	15.39	10.77	1.54
smooth muscle, adult, pool1	10048-101G3	24.81	21.97	16.02	17.06	1.81	0.26
somatostatinoma cell line:QGP-1	10781-110G7	10.72	16.62	10.18	8.04	2.41	0.00
spinal cord - adult, donor10196	10181-103D1	25.69	27.99	23.40	31.20	11.70	0.23
spinal cord, adult, donor10252	10159-103A6	37.85	32.33	27.20	25.23	5.52	0.79
spinal cord, adult, donor10258	10369-105F9	37.36	44.27	22.83	24.90	17.99	0.00
spinal cord, fetal, donor1	10056-101H2	46.35	42.69	32.32	28.05	7.93	0.61
spinal cord, newborn, donor10223	10359-105E8	33.98	64.29	16.99	21.58	10.10	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	31.51	31.22	10.90	9.41	2.84	0.30
spleen, adult, pool1	10025-101D7	67.84	41.63	16.63	14.98	3.08	2.75
spleen, fetal, pool1	10044-101F8	59.27	41.00	16.92	14.30	3.65	1.75
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	41.20	26.29	9.83	10.56	4.14	1.04
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	59.43	46.14	20.89	11.01	3.42	1.52
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	41.93	60.11	28.66	19.57	5.59	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	30.88	36.36	14.07	7.82	5.86	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	33.99	46.04	32.64	24.31	8.55	1.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	40.24	35.16	15.25	11.44	8.47	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	26.23	28.35	8.46	2.96	0.85	0.85
stomach, fetal, donor1	10062-101H8	29.90	24.56	16.02	19.22	8.54	0.00
submaxillary gland, adult	10202-103F4	39.31	34.75	42.73	45.57	7.41	1.71
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	108.55	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	33.03	30.33	25.13	16.82	5.82	0.42
substantia nigra, adult, donor10258	10371-105G2	21.21	39.83	14.48	11.38	9.83	0.00
substantia nigra, newborn, donor10223	10358-105E7	26.14	25.44	14.84	25.44	4.24	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	50.44	46.77	13.76	6.88	3.21	0.92
temporal lobe, adult, pool1	10031-101E4	28.74	27.47	22.80	21.53	6.27	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	55.56	42.74	32.76	30.63	9.97	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	33.84	33.40	14.94	14.94	4.40	1.32
tenocyte, donor1	11763-123H8	43.29	43.29	18.50	9.43	3.14	0.70
tenocyte, donor2	11765-123I1	43.11	37.39	16.40	12.59	4.20	0.00
tenocyte, donor3	11768-123I4	40.77	31.88	16.68	8.90	2.22	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	49.80	45.38	14.11	6.80	1.70	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	36.38	32.37	7.86	5.70	2.93	0.46
teratocarcinoma cell line:PA-1	10807-111A6	45.41	29.60	17.67	9.92	8.52	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	30.09	32.63	18.28	13.71	7.24	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	38.20	40.46	14.37	10.97	3.03	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	19.09	17.34	9.60	8.18	2.40	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	66.12	52.44	24.10	23.78	12.05	4.56
testis, adult, pool1	10026-101D8	46.06	41.55	25.02	26.74	6.66	6.66
testis, adult, pool2	10096-102C6	52.78	96.53	43.30	34.28	20.75	1.80
thalamus - adult, donor10196	10168-103B6	35.33	24.29	23.18	22.08	16.56	0.00
thalamus, adult, donor10252	10154-103A1	33.13	30.16	33.13	20.47	4.69	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	18.48	93.92	3.08	13.86	23.09	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.82	16.63	10.70	15.81	5.93	0.16
thalamus, newborn, donor10223	10366-105F6	33.37	40.27	16.11	18.41	2.88	0.58
throat, adult	10209-103G2	36.20	30.96	21.22	15.98	5.24	2.00
throat, fetal, donor1	10061-101H7	51.80	58.81	35.35	31.38	7.92	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	46.90	29.21	11.92	6.36	3.58	1.79
thymus, adult, pool1	10027-101D9	65.12	34.20	15.01	12.63	3.18	2.19
thymus, fetal, pool1	10043-101F7	59.12	36.05	13.92	11.01	2.29	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	46.94	36.17	15.69	14.63	4.79	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	24.17	27.80	15.23	13.97	5.31	0.84
thyroid, adult, pool1	10028-101E1	63.92	70.26	44.79	36.67	7.84	2.15
thyroid, fetal, donor1	10060-101H6	67.50	75.67	58.53	63.81	15.82	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	9.24	9.24	6.16	0.00	0.00
tongue, adult	10203-103F5	32.79	24.65	16.51	12.79	3.72	1.40
tongue, fetal, donor1	10059-101H5	35.86	37.83	29.56	30.74	8.28	2.76
tonsil, adult, pool1	10047-101G2	71.53	47.78	24.84	21.54	5.61	1.40
trachea, adult, pool1	10029-101E2	56.20	62.41	26.91	16.85	4.83	1.39
trachea, fetal, donor1	10058-101H4	60.01	70.01	38.47	33.85	5.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	35.07	27.99	13.11	6.02	3.19	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	99.29	67.48	23.10	14.29	2.74	2.33
transitional-cell carcinoma cell line:JMSU1	10492-107B6	22.56	29.46	17.55	11.12	2.04	0.63
tridermal teratoma cell line:HGRT	10694-109G1	13.32	11.42	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	37.25	33.78	17.35	11.43	4.83	0.59
umbilical cord, fetal, donor1	10057-101H3	27.12	39.64	25.04	10.43	4.17	0.00
uterus, adult, pool1	10100-102D1	55.97	61.08	32.25	20.99	6.83	1.02
uterus, fetal, donor1	10055-101H1	54.26	51.19	32.76	22.52	5.12	0.00
vagina, adult	10204-103F6	27.79	26.49	18.74	14.22	1.94	0.00
vein, adult	10191-103E2	30.69	20.60	12.49	12.71	3.29	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	40.86	16.02	3.47	1.60	0.00	1.60